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Cancer arises due to the genetic alteration in patient DNA. Many studies indicate the
fact that these alterations vary among patients and can affect the therapeutic effect of
cancer treatment dramatically. Therefore, extensive studies focus on understanding
these alterations and their effects. Pre-clinical models play an important role in cancer
drug discovery and cancer cell lines are one of the main ingredients of these pre-
clinical studies which can capture many different aspects of multi-omics properties
of cancer cells. However, the assessment of cancer cell line responses to different
drugs is faulty and laborious. Therefore, in-silico models, which perform accurate
prediction of drug sensitivity values, enhance cancer drug discovery.
In the past decade, many computational methods achieved high performances by
studying similarity between cancer cell lines and drug compounds and used them
to obtain an accurate predictive model for unknown instances. In this thesis, we
study the effect of non-linear feature selection through two variations of canonical
correlation analysis, KCCA, and HSIC-SCCA, on the prediction of drug sensitivity. To
estimate the performance of these features we use pairwise kernel ridge regression to
predict the drug sensitivity, measured as ln IC50 values. The data set under study is a
subset of Genomics of Drug Sensitivity in Cancer comprise of 124 cell lines and 124
drug compounds.
The high diversity between cell lines and drug compound samples and the high
dimension of data matrices reduce the accuracy of the model obtained by pairwise
kernel ridge regression. This accuracy reduced by employing HSIC-SCCA method as
a dimension reduction step since the HSIC-SCCA method increased the differences
among the samples by employing different projection vectors for samples in different
folds of cross-validation. Therefore, the obtained variables are rotated to provide
more homogeneous samples. This step slightly improved the accuracy of the model.
Keywords: Drug sensitivity, IC50, CCA, KCCA, HSIC-SCCA, pairwise kernel ridge
regression, cancer cell lines.
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11 Introduction
Many complex diseases, such as cancer, arise due to the alteration in the patient
genome. These alterations are responsible for the developments of cancer. Therefore,
the responses to treatment can vary widely from a patient to another. This information
can be used to tailored treatments to target cancer genetics and improve the survival
rate of patients. For example, in the chronic myeloid leukemia, the use of a specific
protein as a target of treatment increased the survival rate of the patient by 5-years in
90% of the treated patients. (Garnett et al., 2012; Garnett and McDermott, 2014; Niu and
Wang, 2015). These improvements are possible by studies in the genome sequencing
and molecular pathology through high-throughput technologies, and bioinformatics
and system biology approach Hoelder et al. (2012). However, obtaining a successful
anticancer treatment is highly challenging due to the extreme diversity between the
genetics of tumors (Lee et al., 2018).
Due to the fact that clinical trials are expensive, time-intensive, and limited to the
known drug compounds, the use of pre-clinical models is highly beneficial. These
pre-clinical models can be used as biological models to stratify patients and accordingly
increase the success rate in the clinical development (Costello et al., 2014; Iorio et al.,
2016; Costello et al., 2014). Among all the pre-clinical model, cancer cell lines show
an extreme capacity in capturing many different genomics aspects of primary tumors.
Additionally, cell lines are renewable sources, and many of genomics data, such as gene
expression measurements, for them are publicly available through online databases
which are constantly accumulating. Therefore, cell lines are considered well-controlled
systems for studying the effect of drug or combination of drugs (Niu and Wang, 2015).
The NCI60 cell line panel is the pioneer in the path of using cancer cell lines for studying
the link between drug sensitivity and genotype data (Garnett et al., 2012).
However, drug sensitivity data sets for cell lines assays are not complete most of
the time due to faulty nature of experiments and measurements machines, and the
pre-clinical experiments to obtain these values are time-consuming, laborious and
expensive. On the other hand, to achieve a more accurate prediction of drug efficacy on
a cell line, increasing the number of samples is highly beneficial. Therefore, an accurate
in-silico model that can predict the therapeutic response of a drug compound on a cell
line, can improve the process of drug discovery (Menden et al., 2013; Cichon´ska et al.,
2018).
Many different machine learning approaches have been suggested for predicting
drug sensitivity. These models integrate different sources of information to improve the
accuracy of their predictions (Jang et al., 2014). For example, in quantitative structure-
activity relationship analysis, chemical and structural features of drug compounds
combined with drug sensitivity to obtain a predictive model (Ekins et al., 2007; Ammad-
ud din et al., 2016). Furthermore, many high-performance predictive models are built
on different genomics measurements combined with the drug sensitivity (Ammad-ud
din et al., 2016). Many successful models combined the cell line features with drug
compound properties to improve the prediction of drug sensitivity. The works by
Ammad-Ud-Din et al. (2014); Costello et al. (2014); Cichonska et al. (2018) are only
a few examples. Additionally, the computational models for this regression task vary
2from linear methods, such as multivariate linear regression, partial least squares, and
principal component regression to non-linear models (Garnett et al., 2012; Barretina
et al., 2012). For example, Menden et al. (2013) used neural networks to build a predictive
model for obtaining drug sensitivity from features of drug compounds and cell lines.
Studies such as Cichonska et al. (2018); Costello et al. (2014) benefits from kernel
methods, and in the work of Ammad-Ud-Din et al. (2014) kernel methods combined
with matrix factorization to construct the predictive models.
One of the main challenges that predictive models for drug sensitivity values are
facing is a large number of variables or features. For instance, each drug compounds
can be described by a large number of features, and the gene expression measurements,
which are important variables for biological samples, can contain tens of thousands of
features. These large numbers of features, make the accurate prediction more difficult.
These difficulties are due to the several reasons such as; the prediction function may
not converge to the optimal solution in a reasonable time, or more accurate prediction
may need a higher number of training data (Liu, 2004).
Among all machine learning methods, kernels are powerful tools in drug sensitivity
prediction because of two main points. Firstly, kernels can extract the non-linear pat-
terns between chemical and genomic features, which can be used in the well-known
linear learning algorithms. Secondly, kernels overcome the time and memory consump-
tion of the predictive models when the original input is high dimensional. That is, when
the number of features is higher than the number of samples such as gene expression in
the cell lines, kernels are able to reduce the data input size by embedding the original
input data to a matrix of size n×n where n is the number of samples in the original data
set (Cichon´ska et al., 2018; Costello et al., 2014; Shawe-Taylor et al., 2004).
Additionally, in the high dimensional data sets, such as biological and chemical data
sets, dimension reduction for input data is often adapted. In the dimension reduction,
it is essential to identify the most relevant variables and the relation between them,
and choose the best smaller subset of variables that maximize the prediction accuracy
(Cichon´ska et al., 2018; Ferreira and Purcell, 2008; Tang and Ferreira, 2012; Inouye et al.,
2012; Marttinen et al., 2013). These methods enhance the prediction by removing irrele-
vant variables from the input space and help the model to find the correct predictive
function in a shorter time and with smaller training set (Liu, 2004; Ma and Huang, 2008).
Among various dimension reduction methods, variations of Canonical Correlation Anal-
ysis (e.i CCA) have been adapted successfully for high-dimensional genomics data. In
the original CCA, proposed by Hotelling (1936), two sets of variables are studied in order
to maximize the correlation between the linear combination of each the variable sets
(Hotelling, 1936). Sparse and regularized variations of CCA were introduced to explore
the multivariate analysis in the underdetermined setting. Additionally, the exploration
of non-linear relations between two data sets has been enhanced by different variations
such as Kernel CCA and Deep CCA (Uurtio et al., 2018b; Andrew et al., 2013; Gretton
et al., 2008).
The ultimate goal of any in-silico model is the accurate prediction of the system
under study. These predictions can be classified into two categories. First, the classifica-
tion prediction e.g. classification of different type of cancers based on their multi-omics
properties. Second, the regression prediction such as predicting the binding affinity
between a target protein and a drug compound (Awada et al., 2012; Cichon´ska et al.,
2018). In this study, we are focusing on the prediction of drug sensitivity, that are real
values, and fall into the regression prediction category. Generally, in order to combine
the strength of the dimension reduction methods with regression prediction, the latent
factors extracted by dimension reduction methods can be used for constructing the
regression models. This procedure has been successfully adapted in several studies
related to the gene expression, such as the paper by Marttinen et al. (2013).
Additionally, kernel ridge regression, a method that combines kernel methods with
the ridge regression (i.e. linear least squares with the l2-norm regularization) is used
to obtain an optimal regression model in several studies. In order to be able to use
the linear least squares cost function for studying data sets with high dimension, the
different regularization term, such as LASSO, elastic net, and l2-norm, are added to
the linear least squares cost function in order to prevent the model from over-fitting
on the train set and control the trade of between training error and model complexity.
Moreover, the systematic studying of the drug sensitivities depends on both cell lines
samples and drug compounds. Thus, the better prediction can be achieved by studying
the similarities among both instances sets, cell lines samples and drug compounds
samples. Therefore, pairwise learning models, that are able to predict based on pairs of
instances such as drug compounds and cell lines, are favorable (Cichon´ska et al., 2018;
Menden et al., 2013; Pahikkala et al., 2014).
The objective of this study is to evaluate the effect of various nonlinear Canonical
Correlation Analysis (i.e. CCA) techniques as dimension reduction for drug-cell line
responses. Therefore, a subset of genomics of drug sensitivity in cancer (GDSC), com-
prises of 124 drug compounds and 124 cell lines, has been selected to evaluate the
accuracy of the obtained model. This data set comprises of 15376 IC50 values of cell
line responses to different drugs and it is publicly available through Wellcome Sanger
institute webpage (Yang et al., 2012). The baseline gene expression values of cell lines,
13321 gene expression has been used as features for cell lines (Ammad-ud din et al.,
2016). Additionally, a set of 588 fingerprints has been used as features of drug com-
pounds (Gasteiger and Engel, 2006). The accuracy of obtained features from non-linear
canonical correlation, HSIC-SCCA (Uurtio et al., 2018a) and KCCA AKAHO (2001); Bach
and Jordan (2002), is evaluated by the accuracy of pairwise kernel ridge regression model
obtained by these features.
The chapters of this thesis are as follow; first, we cover biological background relevant
to the cell lines responses to the different drug compounds. That is, we explain cell lines,
their importance in the drug discovery and their features that can be used for accurate
prediction of their responses to different drugs. Additionally, drugs and some of their
features that are used for similarity search in chemical databases are explained. Next, we
present the computational background and explain the canonical correlation analysis
and several variations of it such as regularized and non-linear CCAs. Moreover, the
kernel methods and pairwise kernel ridge regression are explained in the computational
background. In the material and method section, we focus on our data set. Additionally,
the protocols of the experiment are explained in details in this chapter. The result is
presented in the result and discussion chapter. In the end, the conclusion of this study
has been provided.
42 Biological Background
The somatic mutations in genomes of cells are known to be the emergence of all can-
cers. These mutations modify the function of proteins that are produced by key cancer
genes, thus; not only initiate the cancers but also are responsible for its proliferation.
Many of these alterations are known to be important indicators in the determination
of the responses to the clinical treatment (Garnett and McDermott, 2014; Iorio et al.,
2016; Niu and Wang, 2015). Therefore, the molecularly targeted cancer drug discovery
emerged in order to increase the success rate of cancer treatment by revealing potential
targets in the cancer pathogenetic drivers and genes. There are many ample shreds of
evidence to validate the molecularly targeted therapy (Hoelder et al., 2012).
However, despite recent advances, many more therapeutic options are needed and
the process of introducing new drugs is slow due to the high failure rate. There are two
main reasons for this fact. Firstly, the genomic heterogeneity is significantly high among
tumors, and this includes even those samples that are from the same tissue of origin.
Recognizing these differences and targeting a specific cancer gene in the therapy can
determine the fate of patients. Secondly, due to a large number of cancer genomes were
sequenced, the number of genetic alteration among cancer genomes, both between
different tumors and individual cancer, has been increased dramatically. Therefore,
finding key driver mutations are incredibly complex and challenging (Hoelder et al.,
2012; McDermott and Settleman, 2009). Additionally, validation of new treatments with
the clinical trials is time-intensive, expensive and only restricted to the drugs that their
safety has been verified. Thus, pre-clinical biological models have been employed in
order to provide tractable biological samples that capture molecular features of diseases
and their responses to the different treatments as authentic as possible (Costello et al.,
2014; Iorio et al., 2016).
Among all pre-clinical biological models, human cancer cell lines are one of the
well-established models that are extensively used in the studying of the targeted can-
cer treatment and cancer biology. Many studies, which focused on the comparisons
between cancer cell lines and the original tumors, indicated that cell lines are able to
recapitulate majority of diversity and aberrations among ‘omic’ features of the original
tumors (Costello et al., 2014; Goodspeed et al., 2016; Garnett and McDermott, 2014).
For examples, comparison between breast cancer tumors and their cell lines indicated
the global similarity between gene expression patterns. Additionally, the same resem-
blance has been observed for the copy number alterations (CNA) between breast cancer
tumors and their cell lines (Goodspeed et al., 2016). Furthermore, cancer cell lines are
renewable resources with comprehensive multi-omic data publicly available. All these
reasons make cancer cell lines invaluable in-vitro models in the cancer drug discovery
field (Niu and Wang, 2015; Goodspeed et al., 2016).
On the other hand, most approved drugs are considerably small chemical molecules,
however; not every chemical compound acquires the desirable physicochemical quali-
fication to be a drug. Additionally, the therapeutic effect of drugs on complex disease
such as cancer is affected by the germline and somatic mutation of the patient. That
is, a drug with a positive effect on a patient can be completely ineffective on another
patient due to the different genome background of the patient (Cichon´ska et al., 2018;
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chemical compounds based on their similarity in order to find drug-like compounds
with a higher rate of success in the pre-clinical and clinical trails (Ammad-ud din et al.,
2016; Ammad-Ud-Din et al., 2014).
In the following, first a compact review of cell lines history is given. Then the drug
sensitivity of cell line is explained as a metric for studying the effectiveness of a drug on
a cell line. Then, the gene expression concept, as one of the main feature extracted and
frequently studied in cancer drug discovery, is explained. At the end of this section, drugs
and their features, which can be used for similarity search and studying the therapeutic
effect of drugs and finding new drug compounds, is given.
2.1 Cell Lines as Biological Samples
Cell and tissue cultures have made a large impact on biological science since their
starting point in 1885. Since then there have been several milestones in the cell and
tissue cultures history. One of the most important milestones is using human tissue
for the first time in 1898. Soon after, attempts for longer preservation of a culture
experiment have been made. The continuation of the functionality of cells in-vitro is
illustrated by these experiments and were important in the development of general
techniques in tissue cultures (Langdon, 2010).
In 1951, the first human cancer continuous cell line has been developed, and in the
two decades, the 1950s and 1960s many studies by different scientists have been made
regarding the nutrition of cells in the media. Since the 1970s, an extensive number of
models for a different type of cancers have been provided by a huge number of cell lines
(Langdon, 2010). In 1980, the National Cancer Institute (NCI) established the NCI-60
project, which comprises of 60 human cancer cell lines extracted from 9 different types
of cancers. In this project, extensive omics data for cell lines have been collected and
stored in order to integrate the multi-omics data into the targeted cancer drug discovery
(Niu and Wang, 2015; Goodspeed et al., 2016).
Now by considering this history, we will explain what is a cell culture and a cell
line. The term cell culture indicates the act of removing cells from animals or plants to
observe their growth in a sufficient artificial environment, (Langdon, 2010; Scientific,
2015). The culture is called primary culture when we initializing it by a sample from an
individual. After transferring the diluted prime culture to a new container, it refers to a
cell line. This transferring procedure is called subculture or passage. If the cell line is
able to expand its population indefinitely, it is called a continuous line. On the hand,
when the cell line is capable of a limited number of doubling in the population is called
the finite line, (Langdon, 2010).
In order to evaluate the therapeutic responses of cancer cell lines, the drug dose-
response of cultured cells (i.e. cell lines) need to be measured. Therefore; drug response
assays are used to evaluate the effectiveness and performance of tested compounds.
That is, the drug effectiveness over a range of concentrations has been evaluated and
reported by drug response assays. There are several metrics used to report drug efficacy.
Among all these metrics IC50 is one of most commonly used drug response metric
(Sebaugh, 2011; Niepel et al., 2017; Hafner et al., 2016). In order to obtain the IC50 for
6anti-cancer drugs, cell lines are exposed to a range of concentrations of a drug over a
specific period of time (e.g, 72 hours). For cell lines the reduction in the cell counts
indicates the cell growth inhibition, therefore; the number of viable cells is counted
after the indicated period of time. Specifically, cell counts in the samples treated by
different concentrations of a drug divided by the number of the cells in the untreated
samples (i.e. control sample) are fitted to a sigmoidal curve. The IC50 is indicated by
the concentration of the drug which the number of cells in the treated sample is half of
the control sample (Hafner et al., 2016; Van Meerloo et al., 2011).
In the drug response studies, multi-omics data, such as gene expression, are com-
bined with drug response measurements. Now that a brief overview of the cell culture
and cell lines is given, in the next section we will explain the meaning of gene expression
as an important source of information in biological study. We will start with a review of
what is a gene, what is gene expression, and how it can be measured.
2.1.1 Gene Expression
Our body consists of an enormous number of cells, and each cell contains a nu-
cleus. The complete human genome can be found in almost every nucleus of human
cells. In the human body, the genome defines all cellular structures and activities. The
genome consists of 23 chromosomes pairs. Two huge strands of deoxyribonucleic acid
(DNA) intertwine together and formed a chromosome. Each DNA strand consists of
nucleotides’ sequences and each nucleotide build of a phosphate group, a deoxyribose
sugar, and one of the four nitrogen bases (e.g. Adenine (A), Thymine (T), Cytosine (C),
and Guanine (G)) (Karp, 2009; Schwender et al., 2006).
Segments of a DNA are called genes. Genes are the source of information for con-
structing proteins. All structures and activities of a cell are defined by proteins; therefore,
it is important to study and observe the translation of genes to proteins. Steps of this
procedure are as follow; at first, a single strand of DNA transcribes to an mRNA and
leaves the nucleus. Secondly, each codon (3-mer) of this mRNA is translated to one of 20
possible amino acids and they shape a chain of amino acids. At last, this chain folds into
a protein. This procedure is called gene expression and it is known as Central Dogma of
Molecular Biology (Karp, 2009; Schwender et al., 2006). Figure 1 illustrates the steps of
gene expression procedure.
The expression of genes can be alerted by several factors such as alternative splicing,
binding different transcription factor proteins to the regulatory or promoter regions of a
DNA, and DNA differences between humans. This means a single gene can be coded for
several proteins. Genetic variation, such as deletions or substitutions of bases, are called
mutation, variant or variation. Several diseases are caused by an inherited mutation in
a single gene. Lethal diseases, such as cancer, are known to have many factors, such as
genetic variants and environmental factors. Therefore, it is of high importance to study
several genes and their expression (Schwender et al., 2006; Schwender, 2007).
The distribution and state of proteins in each cell defines the properties and func-
tions of the cells. Therefore, By measuring the protein’s abundance in a cell, the function-
ality of this cell can be studied. However, monitoring the expression level of a protein
is more complex compared to mRNA. Additionally, based on the Central Dogma of
7Figure 1: Central Dogma of the Molecular Biology (Schwender, 2007)
Molecular Biology (Karp, 2009), mRNA measurements also can reveal the cell function.
DNA microarrays are used for measuring the level of expressions for thousands of genes
in a cell (Schwender et al., 2006; Schwender, 2007).
There are a variety of microarrays, but most of them have the same basic princi-
ple that is called complementary base-pairing. The amount of specific mRNA, and
consequently the level of expression for the related gene, is measured as follow;
1 a batch of synthesis complementary DNA probe (i.e. cDNA) corresponding to the
mRNA is placed on the microarray.
2 the desired mRNAs are labeled with a fluorescent dye and fragmented into the
pieces of 25-500 bases.
3 the labeled mRNAs are passed over the microarray to hybridized with the probs
on the microarray.
4 the non-bounded mRNAs are washed away and the array is scanned to measure
the expressed mRNAs. The expression of a specific mRNA is proportional to the
intensity of the fluorescence.
In the aforementioned procedure, each gene (e.g. mRNA) is presented by two
types of cDNA (oligonucleotide) probes. Perfect matches (PM) oligo (short form of
oligonucleotide), that are used to measure the abundance of the specified mRNA,
and Mismatches (MM), that are helpful for correcting the background noise and non-
specific binding, for more details regarding the obtaining the gene expressions and
pre-processing procedure (Schwender, 2007). In some type of microarrays methods,
specially cDNA microarray, two types of mRNA samples are used. One sample is iden-
tical for all arrays and it is called the control sample. The other sample refers to the
8mRNA of our interest (e.g. extracted from a cancer tumor sample). Each of these mRNA
sequences is labeled by the different dye, green and red. The number of relative gene
expressions (over or underexpression) can be calculated by log2 ratio between the
intensity of these two fluorescence dyes (Schwender et al., 2006; Schwender, 2007).
In the next part, we go through to a brief history of advances in the drug discovery.
Then, we talk about how features of chemical compounds can be presented, stored and
used by different computer programs.
2.2 Drug Compounds
After introducing high throughput screening (HTS) in 1980, that enhanced the pro-
cedure of testing different drug compounds on a drug target, the demand for new drug
compounds has increased by biologists. Therefore, a new procedure to construct an
extensive array of compounds by systematically using building blocks of drug com-
pounds (different types of reagents), combinatorial chemistry (CC), has been adopted
by chemists (Xu and Hagler, 2002).
By adopting these new technologies, there were high hopes to facilitate the discov-
ery of new drugs. However, it was not the case due to the fact not all combinations of
different building blocks of different drug compounds can result in a drug candidate. In
the next attempt to provide more drug candidates, the chemically diverse compound
libraries were introduced. These libraries tried to distinguish between the chemical
components by their structures. Different computational approaches, such as classi-
fication algorithms and structural similarity, have been innovated and applied in the
construction of these libraries. These computational methods are ingredients of chem-
informatics discipline (Xu and Hagler, 2002). By adopting these libraries, it has been
indicated that to have a drug candidate, the chemical compound should meet several
conditions such as molecular weight, hydrophobicity, number of rotatable bonds, and
must not contain undesired substructure such as toxicophores (Rhodes et al., 2000).
Thus, in order to reinforce searching for the aforementioned conditions, using
computers to search the chemical data and databases for structures and substructures
has evolved. Structures of chemical components can affect the activities and properties
of those components. Due to this fact, distinctive approaches were introduced to
store and retrieve structures of a chemical compound. There are several approaches to
represent a chemical component. Even a single component can be presented in many
different ways. Therefore, many attempts were made to find a succinct approach to
represent the chemical compound. Graph pretension and linear notations are good
examples of the different structural representation (Xu and Hagler, 2002; Leach and
Gillet, 2007; Gasteiger and Engel, 2006).
2.2.1 SMILES and Fingerprints in Chemical Compound
There are several linear notations methods that represent the chemical structures
by using strings of letters and a set of rules. Simplified Molecular Input Line Entry
Specification (SMILES), introduced by David Weininger, is one of the most popular
methods for linear notation of chemical structures (Weininger, 1988; Xu and Hagler,
92002; Leach and Gillet, 2007). The comprehensive use of SMILES is because most
SMILES strings can be written by simple rules. Some of these rules are given below as
an example;
• Atomic symbols have been used for presenting the atoms.
• Aliphatic atoms are presented by Upper case letters, and aromatics are indicated
by lower case symbols.
• Hydrogen atoms are not presented normally.
• Double bonds are indicated by “=”, and triple bonds by “#”
• Single and aromatic bonds are not illustrated except in some special cases where
they are presented by "-”.
• The rings are indicated by giving an integer number to the two atoms where the
ring is broken.
• The starting point of a branch is illustrated by left-hand brackets, and a right-hand
bracket indicates that all atoms of that branch are seen.
Additionally, in order to construct the SMILES for a chemical molecule, we need to
"walk” through the chemical compound structure in such a way that all the atoms are
visited once (Leach and Gillet, 2007; Weininger, 1988). In Figure 2 two examples of
SMILES are presented for two different chemical compounds.
Figure 2: SMILES presentation of two chemical compound; Trimethoprim and Succini-
cacid (Leach and Gillet, 2007).
SMILES and other linear notation methods have been used to assist the structural
search in computer databases and retrieve information. Additional to the structural
search, substructure searches are applied widely to identify a certain substructure in all
molecules of a database. However, the substructure search is often a slow procedure.
The molecule screens are used to accelerate the search and avoid the atom-by-atom
matching. In the molecular screening method, a bitstring has been provided for both
molecule and query substructure. The bitstring is a sequence of "0”s and "1”s that
indicates the presence or absence of a specified feature structure (a pre-defined sub-
structure) (Leach and Gillet, 2007,?; Xu and Hagler, 2002).
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Pre-defined substructures may not be efficient and contain some biases when the
structures are not seen before. Thus, it is necessary to use systematical approaches to
generate substructures. The negative side effect of using systematical substructures
generation is that the cost of storage and computation increases. To overcome this side
effect, the bit-maps were used. In the bit-maps, a list of substructures is represented
by a bit, and same as bitstrings the "0”s and "1”s are used to illustrate the presence or
absence of a structure. These bit-maps are known as fingerprints (Leach and Gillet,
2007; Gasteiger and Engel, 2006; Xu and Hagler, 2002). In Figure 3 two examples of
fingerprint presentations of two different chemical compounds are given.
H
N
NH2
phenelzine 
0 0 0 0 1 0 1 0 1 1 0 0 0 0 0 0 1 0 1 0 0 0
NH2
OH
O
beta-lapachone 
0 0 0 0 1 0 1 0 1 0 0 0 0 0 0 0 1 0 1 0 0 0
NH2
OH
OO
O
O
CH3
CH3
CH3
Figure 3: Finger print presentation of two chemical compound; Pheneizine and Beta-
lapachone
There are many different fingerprints, and this variety is due to the different sub-
structures that have been used. Daylight fingerprints and MDL fingerprints are two
examples out of many existing fingerprints, there are many more fingerprints listed in
the papers Gasteiger and Engel (2006); Leach and Gillet (2007); Xu and Hagler (2002);
Eckert and Bajorath (2007). The similarity between two different chemical structures
can be computed by fingerprints in a shorter time and by less computational efforts.
Additionally, the same number of fingerprints can be provided for two structures that
are different in the number of atoms and bonds (Xu and Hagler, 2002; Gasteiger and
Engel, 2006; Leach and Gillet, 2007)
The similarity measured based on the fingerprints has been used for identifying the
structures that have similar properties. This simple fact can be used to study the biologi-
cal activities of unknown chemical molecules that have similar structures to a molecule
with known biological activities. That is, an unknown chemical molecule similar to a
molecule with known properties is likely to have the same properties (Willett, 2006).
This fact inspires the rise of machine learning and data mining techniques in studying
similarities between chemical compounds. In other words, obtaining a model that
is capable of mapping several molecular descriptors to different important biological
attributes, and adapting this model predict properties of unknown compounds. There
has been a wide range of machine learning methods employed to study and analysis
chemical molecules, such as support vector machines (SVM), decision tree, artificial
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neural networks, and many others (Lavecchia, 2015).
In this chapter, we presented concepts of cell lines, drug compounds and their
possible feature representations, e.g. gene expressions and fingerprints. Moreover,
we explained the importance of cell lines as a patient avatar in cancer targeted drug
discovery. That is, a cell line can be used as an in-vitro model with the similar features
as the patient to investigate the effect of different drugs or drug-like compounds on
the patient or a type of cancer (Niu and Wang, 2015; Garnett and McDermott, 2014).
A therapeutic effect of a drug on the cell lines is indicated by the drug sensitivity and
the accurate prediction of this value is important. However, testing different drug
compounds on different cell lines is time taking and expensive. Therefore, an in-silico
model that can accurately predict drug sensitivity is highly beneficial Menden et al.
(2013).In the next chapter, we study several machine learning methods that can be used
for similarity search in the drug compounds and cell lines data sets and constructing
predictive models for drug sensitivity.
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3 Computational Background
In this chapter, we explain the computational methods that have been used in this
thesis. First, we start by introducing kernel methods. The kernel ridge regression and
pairwise kernel ridge regression are explained, secondly. In the next step, the basics of
CCA and its regularisation variation (i.e. RCCA) are given. This basic introduction is
followed by describing the non-linearity relation analysis and sparsity in the CCA by
explaining three different methods; sparse CCA (i.e. SCCA), Kernel CCA (i.e. KCCA), and
HSIC-SCCA. In the end, the cross-validation technique for model selection and model
evaluation is explained.
The following notation has been used through this thesis. The matrix X ∈ Rn×p
indicates the sets of measurements over n samples (i.e instances or data points). The
number of features (i.e. variables) is denoted by p. The samples are from an input
space denoted by Rn×p ∈X . In this matrix, the samples are stored as rows vectors in
the matrix and the columns of this matrix correspond to the features. The sample i is
presented as column vector xi , where xi ∈Rp ∈X . Matrix Y ∈Rn contains the output
(i.e. response) measurements of the instances and its output space is indicated byY .
3.1 Kernel Methods
The kernel methods have been employed for the first time in the field of pattern
recognition by Aizerman (1964). However, after many years, it re-appeared in the
concept of machine learning to extend the Support Vector Machine method to a non-
linear classifier (Melzer et al., 2001; Bishop, 2006). Kernel methods are used when a
function consists of a non-linear combination of features only can obtain an accurate
estimation of a label value, either in classification or regression task. Before defining the
Kernel methods, we explain several basic definitions first.
Definition 3.1. Inner product: The inner product (i.e dot or scalar product) of two
input samples x,z ∈ RP can be calculated by 〈x,z〉 =∑pi=1 xi zi , where x and z refer to
individual samples in the input space (Shawe-Taylor et al., 2004).The obtained vectors
from inner product operation construct a gram/kernel matrix and they belong to the
inner product space when they contain only real values (Melzer et al., 2001; Bishop,
2006; Shawe-Taylor et al., 2004).
Definition 3.2. Gram matrix: A gram matrix of a given set of vectors, S = {x1, . . .xl } is a
l × l matrix G with entries equal to Gi j = 〈xi ,x j 〉 (Shawe-Taylor et al., 2004).
Now, by understanding these basic definitions, we can explain kernel methods.
Definition 3.3. Kernel methods: Kernel Methods induce the non-linearity to a linear
function by mapping the features (e.g. variables) of input data set into a nonlinear
feature space. Assume samples are indicated by xi ∈RP where i = 1, . . . ,n is the number
of samples. The Equation 1 represent this mapping (Shawe-Taylor et al., 2004).
φ : x= (x1, x2, · · · , xp ) ∈RP →φ(x)= (φ1(x),φ2(x), · · · ,φs(x)) ∈Rs , s > p. (1)
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A linear function can be presented as wT xi where w ∈Rp is a coefficient vector. The
linear combinations of these obtained mapped features, wTφ(x), can be used as a model
for the prediction task. This new formulation of the predictive model can be expressed
as an inner product of the given feature maps. In the Equation 2, a kernel function is
presented by the inner product of the feature space mapping φ(x).
k(xi ,x j )= 〈φ(xi ),φ(x j )〉 =φ(xi )Tφ(x j ), (2)
where k(xi ,x j ) ∈ Rn×n . A kernel measures the similarity between a pair of samples xi
and x j . However, not every similarity measure can be considered as a valid kernel.
In order to a similarity measure yields, a valid kernel the positive semi-definite (PSD)
criteria should be met.
Definition 3.4. Positive semi-definite: A symmetric matrix X is PSD if uT Xu ≥ 0 for
all non-zero vector u ∈ Rn . In the PSD matrices, all the eigenvalues are non-negative.
Additionally, a matrix X, is symmetric if X= XT (Shawe-Taylor et al., 2004; Cichon´ska
et al., 2018).
Two examples of valid kernels are presented in the Equation 3.
linear kernel: k(x,x
′
)= xT x′
Gaussian kernel: k(x,x
′
)= exp(−x
T x
2σ2
)exp(
xT x
′
σ2
)exp(
−(x′)T x′
2σ2
)
(3)
In order to better understanding of the Equation 2 a simple example is given in the
following. For the sake of simplicity, the input dimension is considered to be two in this
example.
Assume a given data point x= (x1, x2) ∈R2. The following feature map can transform
the given data point in a two-dimensional space into a three-dimensional space.
φ : x= (x1, x2) 7→φ(x)= (x21 , x22 ,
p
2x1x2) ∈R3.
Thus, a linear function in the corresponding feature space can be expressed as following:
f (x)=w11x21+w22x22+w12
p
2x1x2,
where w11, w22, w21 ∈R are the model parameters. As can be seen, this linear function
in the feature space is equivalent to a quadratic function in the input space. Additionally,
the inner product of feature maps for two given data points in the feature space can be
illustrated as follow;
〈φ(xi ),φ(x j )〉 = 〈(xi 21 , xi
2
2 ,
p
2xi1x
i
2), (x
j 2
1 , x
j 2
2 ,
p
2x j1 x
j
2)〉
= xi 21 x j
2
1 +xi
2
2 x
j 2
2 +2xi1xi2x
j
1 x
j
2
= (xi1x j1 +xi2x
j
2)
2 = 〈xi ,x j 〉2,
where i,j correspond to the different samples (i.e data points) in the input space. Thus,
k(xi ,x j )= 〈xi ,x j 〉2 is a kernel function (Shawe-Taylor et al., 2004).
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The kernel methods not only enhance the construction of non-linear predictive
models but also reduce the complexity of the prediction model when the number of
instances is smaller than the number of variables. That is due to the fact that the
prediction no longer depending on the feature size but depending on the sample size
(Melzer et al., 2001; Bishop, 2006; Shawe-Taylor et al., 2004).
Definition 3.5. Hilbert space: An inner product space, such asF , that is separable and
complete is a Hilbert space. Assume h1,h2, . . . ,hN are elements of Hilbert spaceF , and
a ² > 0. If a finite set of elements exists in the space F , for all h ∈F , the condition
min
i
‖hi −h‖ < ², then the space F is separable. Additionally, if all Cauchy sequence
of elements ofF , {hn}n≥1, converge to an element h ∈F . Then we say the spaceF is
complete (Shawe-Taylor et al., 2004).
Definition 3.6. Centering of a gram matrix: In order to move the origin of feature space
to the center of instances in the given data set the centering technique can be employed.
A centered gram matrix is indicated by Kˆ ∈Rn×n in the Hilbert spaceF , and obtained
from the Equation 4.
Kˆ=HKH, (4)
where Hi j = I− 1n 11T and 1 is a vector of ones with size n. Additionally, the sum of the
norms of samples is minimal in the center (i.e origin). The centering of a gram matrix
can affect the sum of eigenvalues of the corresponding gram matrix since The sum of
eigenvalues of a gram matrix is minimized by centering the Gram matrix (Shawe-Taylor
et al., 2004).
Definition 3.7. Reproducing kernel Hilbert space (RKHS): Assume a Hilbert spaceH f
and a point x in this space. Additionally, imagine a point evaluation function δ :H f →R,
which maps any function f ∈H f to f (x) ∈ R. The Hilbert spaceH f is a reproducing
kernel Hilbert space if the point evaluation function is continuous. All reproducing
kernel Hilbert spaces defined by a positive definite kernel Gretton et al. (2005b,a). One
of the main properties of RKHS is that the norm of a given RKHS space Hk can be
calculated by representer theorem. We will define this theorem in the following.
Definition 3.8. Representer theorem(Schölkopf et al., 2001): Assume a non-empty set
X from input spaceX , a positive definite real-value kernel k on the spaceX ×X . More-
over, a training data set comprises of input and responses pairs, (x1, y1), . . . , (xm , ym) ∈
X ×R, a strictly monotonically increasing real value function λ ∈ [0,∞), a class of
functions such asF = { f ∈RX | f (·)=∑∞i=1βi k(·, zi ),βi ∈R, zi ∈X ,‖ f ‖ <∞}, and an
arbitrary loss functionL : (X ×R2)m →R∪∞ are given. The operation ‖·‖ refers to the
norm of a RKHS spaceHk corresponding to k and can be calculated by the Equation 5.
‖
∞∑
i=1
βi k(·, zi )‖2 =
∞∑
i=1
∞∑
j=1
βiβ j k(zi , z j ), (5)
where, zi ∈X is arbitrary unseen samples, βi ∈R are coefficients, and i ∈N is index of
unseen samples. Then any function f ∈F minimizing the regularized loss function,
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L ((x1, y1, f (x1)), · · · , (xm , ym , f (xm)))+λ(‖ f ‖), on the train set can be presented by the
Equation 6.
f (·)=
m∑
i=1
αi k(·, xi ). (6)
The α ∈Rm is a vector of coefficients called a dual variable. The variable m indicates the
number of instances in the training data set (Schölkopf et al., 2001).
3.2 Kernel Ridge Regression and Pairwise KRR
In the prediction task, the aim is to obtain an optimal model based on the labeled
training data which yields the minimum generalization error, that is, error on the test
data set. The labeled training data refers to the samples that their labels (i.e. responses)
are known. Assume the data matrix X as input data from spaceX and matrix Y denotes
the responses from the spaceY . The training data set defines as D = {(xi , y i )}ni=1 where
sample pair xi ∈X and y i ∈Y are sampled from the underlying unknown joint distri-
bution. A set of models,F , maps the input space to the output space,F = { f :X 7→Y }.
In order to obtain the optimal model, f , a loss function that measures the empirical
error, the error between the prediction responses and true responses in the training
data set, is employed. This loss function is defined asL :Y ×Y 7→R and the empirical
risk of the loss function can be calculated by the Equation 7.
R( f )=
n∑
i=1
L (y i , f (xi )). (7)
Therefore, the optimal model f minimises the empirical error R, that is, argminR( f )
f ∈F
(Cichon´ska et al., 2018).
However, minimizing the empirical error R given in the Equation 7 on a specified
training data set can result in overfitting. That means the optimal function f with very
low empirical error can yield high generalization error on unseen data. This situation
can happen due to the noise in the training data set. Therefore, a regularization term is
added to the Equation 7. The obtained optimization problem is given in Equation 8.
argmin
n∑
i=1
L (y i , f (xi ))+λω( f ), (8)
where ω( f ) indicates a function and its values raises as the complexity of the model
increases. The λ≥ 0 refers to the regularization parameter and it controls the tradeoff
between the model complexity and the empirical error. The small norm function is used
often as a regulariser function (Cichon´ska et al., 2018).
The ridge regression, that combines the squared loss function with l2-norm regu-
larise, has been used regularly in the regression prediction. Assume a linear model of
the form f (x)= 〈w,x〉 =wT x=∑txl=1 wl xl , where w ∈Rtx is a vector of model coefficients
obtained by minimising the empirical risk. Additionally, tx is the number of the samples
in the training set. The squared loss function isL (y i , f (xi ))= (y l − f (xl ))2. Therefore,
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the ridge regression is defined as Equation 9.
argmin
w
tx∑
l=1
(y l −〈w,xl〉)2+λ‖w‖2 = argmin
w
〈y−Xw,y−Xw〉+λ〈w,w〉. (9)
The solution for the optimal coefficient of the model can be calculated by derivatives
of the Equation 9 with respect to w and setting them equal to zero vector. The optimal
w is calculated by the Equation 10.
w= (XT X+λIt x)−1XT y, (10)
where It x refers to the identity matrix of the size Rtx×tx (Cichon´ska et al., 2018; Saunders
et al., 1998).
3.2.1 Kernel Ridge Regression
Kernels can be used in ridge regression to induce non-linearity to the model. The op-
timal prediction function for the Kernel ridge regression can be obtained by representer
theorem, presented in (Schölkopf et al., 2001; Kimeldorf and Wahba, 1971).
The reprensenter theorem can be used in order to obtain the function f that min-
imized regularized empirical error. Thus, the function f in the Equation 8 can be
presented in the Equation 11.
f (z)= 〈w,z〉 =
m∑
i=1
αi 〈xi ,z〉 =
m∑
i=1
αi kx(x
i ,z)=αT kx , (11)
where kx is a vector comprises of kernel values between samples of the training set,
xi , and test samples, z. Therefore, coefficient vector w can be obtained as a linear
combination of training samples. This is presented in the Equation 12.
w=
m∑
i=1
αi xi =XTα. (12)
Additionally, the Equation 9 can be rewrite as minimizing problem of the form∑m
i=1 ζ
i 2+λ‖w‖2 with constraints ζi = y i −wT xi and i = 1, . . . ,m. The Lagrange mul-
tipliers αi can be used in order to obtain
∑m
i=1 ζ
i 2 +λ‖w‖2 +∑mi=1αi (yi −wT xi − ζi ).
The solution for coefficient vector w can be obtained by differentiating the mentioned
equation with respect to w and it is equal to w= 1λ
∑m
i=1α
i xi (Saunders et al., 1998).
The solution to kernel ridge regression (i.e. ridge regression in the dual space) can
be acquired by reforming the Equation 10 into w=λ(−1)XT (y −Xw)=XTα. The closed
form solution presented in the Equation 13.
α=λ(−1)(y −Xw),
λα= (y −XXTα),
(XXT +λTn)α= y,
(Kx +λIn)α= y,
α= (Kx +λIn)−1 y,
(13)
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where Kx = xxT refers to the kernel matrix comprises of the inner products of the training
samples. The prediction for the test instance z can be calculated by the Equation 11
when the α is computed on the training set (Cichon´ska et al., 2018; Saunders et al.,
1998).
3.2.2 Pairwise Kernel Ridge Regression
In the case of pairwise learning, each instance comprises of two individual parts,
which are presented by separate features. Therefore, the training samples can be pre-
sented as D = (X1,X2,y) ∈ (X1×X2×Y ), where X1 ∈ Rn×p and X2 ∈ Rm×q are feature
matrices of part one and part two respectively. The vector y ∈RN stores the labels for
sample pairs and N ≤ p ·q . Thus, the goal in the pairwise learning is to obtain an optimal
prediction function f :X1×X2 7→Y that captures the relationship between pairs of
samples, (X1,X2), and their labels y (Cichon´ska et al., 2018; Pahikkala et al., 2013).
By adopting a pairwise kernel k in the KRR, the KRR can be used for a pairwise
learning problem. The Kronecker product pairwise kernel is the most favorable choice
for measuring the similarity between sample pairs. The Kronecker product of two
kernels, k1 :X1×X1 7→R and k2 :X2×X2 7→R is given in the Equation 14.
k
(
(xi1,x
i
2), (x
j
1,x
j
2)
)
= k1(xi1,x j1).k2(xi2,x
j
2), (14)
where, xi1,x
j
1 refer to different samples in data matrix X1, and x
i
2,x
j
2 indicate individual
samples in data matrix X2. That is, the pairwise kernel K ∈Rn×n between two kernels
K1 ∈Rn×n and K2 ∈Rm×m is a block matrix and contains all possible products of samples
in both kernel. The Equation 15 presents the Kronecker product in more details.
K=K1⊗K2 =

k1(x11,x
1
1)K2 k1(x
1
1,x
2
1)K2 · · · k1(x11,xn1 )K2
k1(x21,x
1
1)K2 k1(x
2
1,x
2
1)K2 · · · k1(x21,xn1 )K2
...
...
. . .
...
k1(xn1 ,x
1
1)K2 k1(x
n
1 ,x
2
1)K2 · · · k1(xn1 ,xn1 )K2
 , (15)
where⊗ indicates the Kronecker product and xn1 refers to the nth samples in data matrix
X1. The pairwise kernel K, obtained from Kronecker product, can substitute the Kx in
the equation 13. The solution for pairwise KRR is given in the Equation 16.
α= (K+λIN )−1 y. (16)
It easily can be observed that the size of pairwise kernel K increases rapidly with the
growth in the number of samples. Therefore, obtaining a model on the train set can
be computationally infeasible regarding both memory and time usage. However, this
problem can be overcome by using several algebraic properties of the Kronecker product.
These computational short-cuts can be used to accelerate the training phase. Before
explaining these short-cuts, several algebraic properties are presented first (Cichon´ska
et al., 2018).
The vectorization operator, vec(·), stores the columns of a matrix into a vector.
For instance, imagine matrix Y ∈ Rn×m then vec(Y) = y. Additionally, for to arbitrary
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matrices A and B, we have; (A⊗B)vec(D) = vec(BDAT ), (A⊗B)(D⊗E) = (AD)⊗ (BE),
and (A⊗B)−1 =A−1⊗B−1.
Now by knowing these properties, we explain the computational short-cut. Given
two data matrices X1 and X2 and their Kronecker product K, the eigenvalue decomposi-
tion of the Kronecker product matrix can be obtained from the eigenvalue decompo-
sition of each data matrix. That is, if K1 =U1Λ1U−11 and K2 =U2Λ2U−12 are eigenvalue
decompositions of both data matrices where U1 ∈Rn×n and U2 ∈Rm×m are orthogonal
matrices comprise eigenvectors in their columns and Λ1 ∈ Rn×n and Λ2 ∈ Rm×m are
diagonal matrices that store corresponding eigenvalue of K1 and K2 the pairwise KRR
with the Kronecker product has a closed form and it is presented in the Equation 17.
α= (K1⊗K2+λIN )−1vec(Y)
= ((U1Λ1U−11 )⊗ (U2Λ2U−12 )+λIN )−1vec(Y)
= ((U1⊗U2)(Λ1⊗Λ2+λIN )(U−11 ⊗U−12 ))−1vec(Y)
= (U1⊗U2)(Λ1⊗Λ2+λIN )−1(U−11 ⊗U−12 )vec(Y)
= (U1⊗U2)(Λ1⊗Λ2+λIN )−1vec(UT2 YU1)
= (U1⊗U2)vec(R)
= vec(U2RUT1 ),
(17)
where vec(R)= (Λ1⊗Λ2+λIN )−1vec(UT2 YU1). Additionally, the Kronecker product
of two diagonal matrices yields a diagonal matrix. Thus, di ag (Λ1⊗Λ2)= di ag (Λ1)⊗
di ag (Λ2)= vec(di ag (Λ2)di ag (ΛT2 )). By using this property we can prevent the explicit
construction of any enormous Kronecker product matrix. Similar to the KRR, in the
pairwise KRR the prediction for a unseen sample pair, (z1,z2), can be obtain by using
the Equation 18.
f (z1,z2)= kTα= (kT1 ⊗kT2 )α= (kT1 ⊗kT2 )vec(U2RUT1 )= kT2 (U2RUTd )k1, (18)
where the kernel values between unseen instances of the data matrix X1, z1, and each
train samples of the same data matrix, x1, are stored in the vector k1, whereas, k2 is a
vector comprises of kernel values between unseen samples of the data matrix X2, z2,
and train samples of the data matrix X2, x2 (Cichon´ska et al., 2018; Pahikkala et al., 2013)
3.3 Canonical Correlation Analysis
In 1936, Hotelling introduced Canonical Correlation Analysis (i.e. CCA) to statistical
study for two-view multivariate Hotelling (1936). Since then this method has been used
in many fields such as economics, psychology, geography, medicine, chemistry, and etc.
In the past decade, CCA has been used commonly in the modern field such as machine
learning and data analysis, bioinformatics and computational biology, neuroscience.
In these studies, CCA has been employed for dimensionality reduction (Uurtio et al.,
2018b).
Canonical Correlation Analysis reviles the linear relationships between two vari-
able sets, (Thompson, 2005). These variable sets (also called views) indicate different
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measurements on a set of individuals (i.e. observation or samples), (Thompson, 2005;
Uurtio et al., 2018b). One good example of different variable sets can be found in medi-
cal studies. Assume the information of several patients (i.e. samples) having a specific
disease can be divided and store in two different variable sets;
1 Variables that describe the clinical symptoms of the disease,
2 Biological data (e.g gene expression, and mutation) extracted from tissue samples
of patients.
These views, we call them view a and view b, are denoted by two row matrices
Xa ∈Rn×p and Xb ∈Rn×q , respectively. The samples are considered to be from a normal
multivariate distribution. Additionally, features (variables) for n sample are presented
by column vectors ai ∈ Rn for i = 1,2, · · · , p and b j ∈ Rn for j = 1,2, · · · , q (Uurtio et al.,
2018b; Anderson et al., 1958).
The aim of canonical correlation analysis is to find a pair of linear transformation
that maximizes the correlation between transformed variable sets. This transformation
can be obtained by an inner product between a pair of weight vector and variables.
These weight vectors are referred to as canonical weight vectors (in short canonical
vectors) in literature. Variable sets Xa ∈Rn×p and Xb ∈Rn×q can be linearly transformed
by canonical weight vectors wa ∈Rp and wb ∈Rq , respectively as follow;
〈Xa ,wa〉 = za and 〈Xb ,wb〉 = zb ,
where za ∈ Rn and zb ∈ Rn , which are also called as canonical variables or canonical
scores (Uurtio et al., 2018b; Anderson et al., 1958).
The CCA method endeavors to maximize the correlation between image vectors (i.e.
canonical variables) za and zb in the common subspace Rn . That is, the cosine of the an-
gle between images za and zb , which can be calculated by formula cos(za ,zb)= <za ,zb>‖za‖‖zb‖ ,
is equivalent to the correlation (measure of closeness) between images. Therefore, the
aim in CCA is to minimize the angle between two images za and zb . In order to obtain
unique values for the canonical weight vectors, they are constrained to be unit norm
vectors and their enclosing angle is considered to be θ ∈ [0, pi2 ]. The cosine of the angle θ
is referred to as the canonical correlation in the literature. Due to the unit norm con-
straint the former formula is equal to cos(za ,zb)= 〈za ,zb〉 (Uurtio et al., 2018b; Golub
and Zha, 1995).
The first canonical correlation between the canonical variables (i.e. images) za
and zb of position vectors (i.e. canonical weight vector) wa and wb result in the highest
correlation. That is, the smallest angle, θ1, between images za and zb . The cosθ1 indicate
the first canonical correlation. Therefore;
cosθ1 = max
za ,zb∈Rn
〈za ,zb〉,
‖za‖2 = 1 ‖zb‖2 = 1.
(19)
If we consider the z1a and z
1
b are the first pair of canonical variables that determine the
maximum correlation, the second pair of canonical variables, z2a and z
2
b , are orthogonal
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to the first pair and has the second smallest enclosing angle θ2. Thus, r finite number
of pairs for canonical variables can be found recursively by removing all previous pairs
from orthogonal complements set of canonical variables. All the r enclosing angles
between pairs, θr ∈
[
0, pi2
]
for r = 1,2, · · · , q when p > q , are found in the ascending order
and can be determined as presented in the Equation 20.
cosθr = max
za ,zb∈Rn
〈zra ,zrb〉,
s.t.
∥∥zra∥∥2 = 1 ∥∥zrb∥∥2 = 1,
〈zra ,z ja〉 = 0 〈zrb ,z
j
b〉 = 0,
∀ j 6= r : j ,r = 1,2, · · · ,mi n(p, q).
(20)
Additionally, it can be seen that the number of pairs of canonical variables, r , indicate
the dimensionality of CCA, and consequently; is equal to the number of patterns that
are extracted from the data. The importance of these found patterns, all the canonical
weight vector wa and wb and all canonical variables (i.e. images) za and zb , is indicated
by canonical correlation and they tend to decrease as the number of patterns increase
(Uurtio et al., 2018b).
There are several methods introduced for obtaining the canonical weight vector wa
and wb and respectively canonical variables za and zb . The original method, proposed
by Hotelling (1936), includes solving a standard eigenvalue problem. In 1957, Healy
proposed a singular value decomposition (SVD) based solution to find the positions and
the images of the CCA method (Healy, 1957). In 2002 and 2004, a generalized eigenvalue
problem has been suggested in the works of Bach and Jordan (2002); Hardoon et al.
(2004) for obtaining the canonical variables. In the following, we explain the original
method proposed by Hotelling, using standard eigenvalue method for solving CCA.
Standard Eigenvalue Technique for Solving CCA
Hotelling proposed the use of standard eigenvalue problem in order to obtain both
pairs of canonical weights, wa and wb , and pairs of canonical variables, za and zb . In
his suggested solution, the characteristic equation is obtained by using the Lagrange
multiplier. Let assume two data matrices Xa and Xb of sizes n×p and n×q . Then the
covariance matrix of samples, donated by Cab , is calculated by Cab = 1n−1 XTa Xb between
variables of data matrices Xa and Xb . Moreover, the empirical variance matrices for data
matrices Xa and Xb are obtained by Caa = 1n−1 XTa Xa and Cbb = 1n−1 XTb Xb , respectively.
The joint covariance matrix is constructed as given in the Equation 21.(
Caa Cab
Cba Cbb
)
. (21)
The angle between the first pair of canonical variables (i.e. images) za = Xawa
and zb = Xbwb is the smallest angle and consequently, it corresponds to the highest
correlation. The correlation between a pair of canonical variables za and zb is not
depending on the scale of them, therefore; a constraint can be considered for canonical
weight vector wa and wb in order to canonical variables za and zb have unit variance
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(Hotelling, 1936; Uurtio et al., 2018b). Therefore; the following can be obtained:
zTa za =wTa XTa Xawa =wTa Caawa = 1, (22)
zTb zb =wTb XTb Xbwb =wTb Cbbwb = 1. (23)
The variables of Xa and Xb are considered to be centered and have zero means, thus,
they are considered to be normally distributed and comparable. Under this condition,
the covariance between two canonical variables za and zb can be obtained by the
Equation 24:
zTa zb =wTa XTa Xbwb =wTa Cabwb . (24)
Accordingly, we can use Equations 22, 23, and 24 and substitute them in the Equation
19 to obtain the Equation 25.
cosθ =max〈za ,zb〉 =max〈wTa Ca,bwb〉,
‖za‖2 =
√
wTa Caawa = 1 ‖zb‖2 =
√
wTb Cbbwb = 1.
(25)
The solution for the aforementioned problem can be acquired by using the Lagrange
multiplier techniques. The Lagrange formulation of the Equation 25 is as the Equation
26.
L =wTa Cabwb −
λ1
2
(wTa Caawa −1)−
λ2
2
(wTb Cbbwb −1), (26)
where λ1 and λ2 refer to the Lagrange multipliers. To find the solution wa and wb for
the Equation 26 we differentiating L with respect to wa and wb . Additionally, we know
that both wTa Caawa = 1 and wTb Cbbwb = 1, thus it easily can be proved that λ1 =λ2 =λ.
Therefore, the solution for optimal wa can be obtain by Equation 27.
wa =
C−1aaCabwb
λ
, (27)
and consequently Equation 28 is obtained.
1
λ
CbaC
−1
aaCabwb −λCbbwb = 0, (28)
by manipulating the Equation 28 we can obtain a generalized eigenvalue problem as in
the Equation 29;
CbaC
−1
aaCabwb =λ2Cbbwb . (29)
The above equation can be reduced to a standard eigenvalue problem if Cbb is invertible.
This equation is illustrated in the Equation 30;
C−1bb CbaC
−1
aaCabwb =λ2wb . (30)
Thus, the CCA can be solve by a standard eigenvalue solution of the matrix C−1bb CbaC
−1
aaCab
have eigenvalues. These eigenvalues can be found by solving the Characteristic Equa-
tion 31;
|C−1bb CbaC−1aaCab −λ2I| = 0. (31)
The canonical correlations are equal to the square roots of the acquired eigenvalues
(Hotelling, 1936; Uurtio et al., 2018b).
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3.3.1 Extending the CCA by Regularisation Technique
The CCA has been adopted in the studies that the number of observations is higher
than the number of variables in both views. The singularity of variance matrices Caa
and Cbb can cause that these matrices cannot be inverted when we want to employ the
standard eigenvalue technique to solve the CCA. Moreover, the square-root factors of
singular variance matrices Caa and Cbb my not exist when the SVD method has been
adopted. If the number of observations exceeds the number of variables, the singularity
of variance matrices possibly will overcome. On the other hand, if the number of
observations is less than the number of variables the collinearity between the variables
increases. For the first time, Vinod proposed a solution to tackle the collinearity problem
in the studies with the insufficient sample size (Uurtio et al., 2018b). This technique is
called regularisation and in the following, we give an overview of this popular technique.
In the work of Vinod (1976) the singularity problem is adopted, and it is proposed to
add a regularisation term to the diagonal of both variance matrices. These regularisation
values are arbitrary constant that improves the variance matrices’ invertibility. In the
Equation 32, the modified constraints of CCA that use the constructed variance matrices
by additional regularized constant c1 ≥ 0 and c1 ≥ 0 is illustrated.
wTa (Caa + c1I)wa = 1,
wTb (Cbb + c2I)wb = 1.
(32)
In comparison with the original method, the magnitudes of the canonical weight
vectors, wa and wb , in the regularised CCA are smaller due to the additional regulari-
sation term in the Equation 32. Hence, the constraints of the regularised CCA in the
optimization problem is changed as it is presented in the Equation 33.
cosθ = max
wa∈Rp ,wb∈Rq
(wTa Cabwb),
s.t wTa (Caa + c1I)wa = 1 wTb (Cbb + c2I)wb = 1.
(33)
The same as in the case of original CCA, the canonical weight vectors in the reg-
ularised CCA can be obtained by employing standard and generalized eigenvalues
techniques Uurtio et al. (2018b). These two solutions are presented in the Equations 34
and 35, respectively.
(Cbb + c2I)−1 Cba (Caa + c1I)−1 Cabwb =λ2wb , (34)
(
0 Cab
Cba 0
)(
wa
wb
)
=λ
(
Caa + c1I 0
0 Cbb + c2I
)(
wa
wb
)
. (35)
Similar to the CCA method, The canonical correlations of the regularised CCA is
obtained by the inner product of each pair of canonical variables < zia ,zib >, where
i = 1,2, · · · ,mi n(p, q).
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3.3.2 Introducing Sparsity to the the CCA Method
In both cases of CCA and regularised CCA, the entries of the canonical correlation
weight vectors indicate the linear relation between the variables. These relations are
interpretable when the number of variables is not high. Nevertheless, more often the
number of variables in the modern datasets is much higher than it could be sufficient
for the human to study and interpret them. To avoid such a problem, the coefficient
of the canonical weight vectors should be constrained in a way that the only subset of
them obtain non-zero value.
In order to enforce sparsity into the canonical weight vectors, the soft-thresholding
operators have been used on the canonical weight vectors. Thus; a subset of variables
will obtain non-zero weight and the linear relation between these entries of canonical
weight vectors can be studied in the data space. This method has been proposed by
Parkhomenko in 2007 for the first time and does not require prior knowledge over the
variables of each view (Parkhomenko et al., 2007; Uurtio et al., 2018b).
The canonical weight vectors are obtained by using the SVD method as it has been
presented in the original CCA method. The sparsity has been induced by sparse singular
value decomposition of the matrix C
− 12
aa CabC
− 12
bb . Accordingly, the left and right orthonor-
mal singular vectors, U and V, have sparse entries by applying the L1 norm constrain on
them. To find the sparse canonical weight vectors by using SVD technique the recursive
Algorithm 1 has been proposed by Parkhomenko et al. (2007).
Algorithm 1: Sparse Canonical Correlation Analysis Algorithm
1 Initialization: Select the sparsity indicators ca and cb for both canonical weight
vector. Initialize the canonical weight vectors u0 and v0, and set i = 0;
2 repeat
3 Update the left vector u as follows:
4 a- ui+1 =C−
1
2
aa CabC
− 12
bb vi and normalize it
5 b- Soft-thresholding: ui+1 =
(∥∥ui+1− 12 ca∥∥)+ si g n(ui+1)
6 c- Normalizing ui+1 again
7 Update the right vector v as follows:
8 a- vi+1 =C−
1
2
aa CabC
− 12
bb ui+1 and normalized it
9 b- Soft-thresholding: vi+1 =
(∥∥vi+1− 12 cb∥∥)+ si g n(vi+1)
10 c- Normalizing vi+1 again
11 until Until convergence;
12 return u, v
The algorithm 1 returns the first canonical weight vectors pair. In order to obtain the
consecutive pairs of canonical weight vectors, the matrix C
− 12
aa CabC
− 12
bb should be deflated
and the new patterns can be found by using SVD techniques on the obtained matrix
(Parkhomenko et al., 2007; Uurtio et al., 2018b).
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3.3.3 Kernel Canonical Correlation Analysis
The CCA methods originally is used for finding the linear relation between variables
of two views in the data space, Xa ∈ Rn×p and Xb ∈ Rn×q where n is the number of
samples, and p, q correspond to the number of variables in view a and b, respectively.
The images (i.e. canonical variables) za and zb are obtained by inner product of position
vectors (canonical weight vectors) wa ∈Rp and wb ∈Rq and corresponding views, za =
Xawa and zb =Xbwb . These canonical weight vectors are obtained such as the enclosing
angle between their corresponding image is minimized and they indicate the relations
between the features in each view. Both canonical weigh vectors wa and wb and their
corresponding canonical variables za and zb are acquired in the data space which
is Euclidean space; therefore, only the linear relation can be extracted (Uurtio et al.,
2018b).
The non-linear relations between features can be extracted when the canonical
weight vectors wa and wb are obtained in non-linear feature space. To this end, the
kernel method can be used. Firstly, the original samples, Xia and X
i
b where i = 1,2, · · · ,n
correspond to the sample size, are mapped into non-linear Hilbert spaceHa andHb .
These feature maps are presented in the equation 36.
φa :R
p 7→Ha
φb :R
q 7→Hb .
(36)
Then, symmetric positive semi-definite kernels are employed in order to capture the
similarity between samples through an inner product of obtained high dimensional
Hilbert (i.e. feature) spaces. The Equation 37 demonstrate these kernels.
Ka(x
i
a ,x
j
a)= 〈φa(xia),φa(x ja)〉Ha
Kb(x
i
b ,x
j
b)= 〈φb(xib),φb(xb j )〉Hb .
(37)
These feature maps are non-linear; therefore, by substituting these kernels obtained
from non-linear feature maps, instead of covariance matrices in Equations 22 and 23,
the non-linear correlation between variables can be extracted (Bach and Jordan, 2002;
Hardoon et al., 2004; Uurtio et al., 2018b). The kernel CCA is illustrated in the Figure 4.
The same as the original CCA, the canonical correlation vectors, α ∈Rn and β ∈Rn ,
are obtained in the feature space in such a way that minimizes the enclosing angle be-
tween canonical variable, za and zb on the unit ball in Rn (Uurtio et al., 2018b; Hardoon
et al., 2004). Therefore, the kernel CCA can be expressed as in the Equation 38.
cos(za ,zb)= max
za ,zb∈Rn
〈za ,zb〉 =αT KTa Kbβ,
s.t ‖za‖2 =
√
αT K2aα= 1
‖zb‖2 =
√
βT K2bβ= 1,
(38)
where the constraints are applied to guarantee the uniqueness of obtained canonical
weight vectors. The Lagrange multiplier method can be applied to solve the optimization
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Figure 4: Kernel canonical correlation; Xa and Xb indicate the data matrices in view
a and b respectively. φa and φb are feature maps for each view that map data points
the into non-linear Hilbert spacesHa andHb , respectively. α and β are the canonical
weight vectors obtain in the feature space (AKAHO, 2001).
problem. This optimization problem is given in the Equation 39.
L =αT KTa Kbβ−
λ1
2
(αT K2aα−1)−
λ2
2
(βT K2bβ−1), (39)
where λ1 and λ2 are the Lagrange multipliers. In order to acquire an optimize solution
for canonical weight vectors, we drive the Equation 39 with respect to α and β. These
derivation are shown in the Equations 40 and 41.
δL
δα
=KaKbβ−λ1K2aα= 0, (40)
δL
δβ
=KbKaα−λ2K2bβ= 0. (41)
By Multiplying the αT into the Equation 40 from the left side and βT into the Equation
41 from the left side result in the Equations 42 and 43.
αT KaKbβ−λ1αT K2aα= 0, (42)
βT KbKaα−λ2βT K2bβ= 0. (43)
From the Equation 38 we know thatαT K2aα= 1 and βT K2bβ= 1; therefore, the result
λ1 = λ2 = λ is obtained and by substituting it in the Equation 40, the optimized α
determined by Equation 44.
α= K
−1
a K
−1
a KaKbβ
λ
= K
−1
a Kbβ
λ
. (44)
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Additionally, by replacing the alpha in the Equation 41 byα obtained by the Equation
44, the solution for the optimize β is calculated as in the Equation 45.
1
λ
KbKaK
−1
a Kbβ−λK2bβ= 0. (45)
As it can be seen in the Equation 46, the generalized eigenvalue problem is formed
by removing KaK−1a .
K2bβ=λ2K2bβ. (46)
The generalized eigenvalue problem Equation 46 can simplified to a standard eigenvalue
problem as in the Equation 47, when the kernel K2b is invertible.
Iβ=λ2β, (47)
where the canonical correlation is stored in λ and β correspond to the canonical weight
vectors in the feature space. In the feature space, all the Gram matrices are invertible.
This means that λ= 1 for all canonical weight vectors,α and β, and perfect correlation
can be found (Hardoon et al., 2004; Uurtio et al., 2018b). This is because of the high-
dimensionality of the feature space that is provided by kernel methods. Therefore,
no meaningful result can be obtained from such naive application and the obtained
non-linear relations between features are not explaining the input data sets under
investigation. This is due to the over-fitting problem that occurs by high-dimension
feature spaces (Hardoon et al., 2004).
In order to overcome the over-fitting problem in the kernel CCA method, regular-
isation technique is applied. This regularized parameter is applied on the norms of
canonical weights vectors,α and β, to control the flexibility of projection through pe-
nalized factor (Hardoon et al., 2004; Bach and Jordan, 2002). The Equation 48 clarify the
new constraint of canonical weight vector with additional regularised constant.
αT (Ka + c1I)2α= 1,
βT (Kb + c2I)2β= 1.
(48)
As it can be seen the scalar regularisation values are added to the diagonal of the Gram
matrices, Ka and Kb (Uurtio et al., 2018b). The result of the regularized kernel CCA can
be obtained through the standard eigenvalue problem given in the Equation 49.
(Kb + c1I)−2KbKa(Kb + c2I)−2KaKbα=λ2α. (49)
Additionally, the same as the original CCA method, the generalized eigenvalue method
can be employed in order to solve the kernel CCA. This can be obtained by replacing the
data matrices, Xa and Xb , with their corresponding Gram matrices, Ka and Kb (Hardoon
et al., 2004; Uurtio et al., 2018b; Bach and Jordan, 2002). The solution of the generalized
eigenvalue problem is presented in the Equation 50.(
0 KaKb
KbKa 0
)(
α
β
)
=λ
(
(Ka + c1I)2 0
0 (Kb + c2I)2
)
(50)
27
The projection vectorsα and β are obtained in the high-dimensional Reproducing
Kernel Hilbert Space (i.e feature spaces) Ha and Hb ; therefore, they are not inter-
pretable in the input space. That is, investigating the relation between original features
is not possible in the kernel CCA. Additionally, kernel CCA considers all the variable in
both views Xa and Xb and does not remove the irrelevant features and eventually affect
the robustness of kernel CCA. The careful selection of the regularization parameter can
overcome the latter problem (Chang et al., 2013).
3.3.4 Sparse Canonical Correlation Analysis through Hilbert-Schmidt Independence
Criterion Optimization
In this section, we go through an extension of CCA that allows us;
1) Find linear and non-linear relations among variables of two views while inducing
sparsity.
2) Obtain multiple canonical weight vectors that are interpretable (Chang et al., 2013;
Uurtio et al., 2018a).
This sparse variation of CCA (i.e. HSIC-SCCA) use Hilbert-Schmidt Independence
Criterion in order to find (in)dependency among variables of each view. Firstly, we go
through some definition that is essential for understanding HSIC-SCCA method.
Definition 3.9. Hilbert-Schmidt Norm: The Hilbert-Schmidt (HS) norm of a linear
operator C (i.e. C :G →F ) can be calculated through Equation 51.
‖C‖2HS :=
∑
i , j
〈C v j ,ui 〉2F , (51)
ui and v j indicate orthonormal bases for two RKHSF andG respectively (Gretton et al.,
2005a).
Definition 3.10. Cross-Covariance Operator: Assume two topological separable spaces,
X and Y , and two Borel sets, Γ and Λ, such as (X ,Λ) and (Y ,Γ) that have probabil-
ity measurements px and py , respectively. A linear operator Cx y : G →F is a cross-
covariance operator on (X ×Y ,Γ×Λ) with joint probability measurement px,y and it
can be obtain as in the Equation 52.
Cx y :=Ex,y [(φ(x)−µx)⊗ (ψ(y)−µy )]=Ex,y [φ(x)⊗ψ(y)]︸ ︷︷ ︸
:=Cˆx y
−µx ⊗µy︸ ︷︷ ︸
:=Mx y
, (52)
where the mean elements, µx and µy , can be obtained by using the Equation 53 when
F and G are two RKHS, and f ∈F and g ∈G .
〈µx , f 〉F :=Ex[〈φ(x), f 〉F ]=Ex[ f (x)],
〈µy ,g 〉G :=Ey [〈ψ(y),g 〉G ]=Ey [g (y)]
(53)
In the aforementioned equation, φ and χ are feature maps fromX andY toF and G
respectively (Gretton et al., 2005a).
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Definition 3.11. Hilbert-Schmidt Independence Criterion: The Hilbert-Schmidt In-
dependence Criterion for two given separable RKHSF and G and a joint probability
measurement px y on (X ×Y ,Γ×Λ) can be calculated with the Equation 54.
HSIC (px y ,F ,G ) := ‖Cx y‖2HS , (54)
where Cx y refers to cross covariance operator. The Equation 54 can be obtain through
kernel functions as presented in the Equation 55.
HSIC (px y ,F ,G )=Exi ,x j ,y i ,y j [ka(xi , x j )l (y i , y j )]+Exi ,x j [k(xi , x j )]Ey i ,y j [l (y i , y j )]
−2Exi ,y i [Ex j [k(xi , x j )]Ey j [l (y i , y j )]],
(55)
where k and l are bounded kernels (i.e. Exi ,x j [k(x
i , x j )]<∞ and Ey i ,y j [l (y i , y j )]<∞),
and Exi ,x j ,y i ,y j indicates the expectation value of the independent pairs (x
i , y i ) and
(x j , y j ) obtain from px y (Gretton et al., 2005a).
The approximation of HSIC (px y ,F ,G ) over a finite number of independent obser-
vations, n, in the two RKHSF and G can be obtain with the Equation 56.
HSIC (Z ,F ,G ) := tr ace(Kˆ Lˆ)
(n−1)2 , (56)
where Z refers to a set of independent observations drawn from px y , Z := {(x1, y1),
(x2, y2), · · · , (xn , yn)}⊆X ×Y , and Kˆ ∈ Rn×n and Lˆ ∈ Rn×n are centred Gram matrices,
in the Hilbert spacesF and G Additionally, the HSIC can be calculated empirically by
centring only one of the Gram matrices (Gretton et al., 2005b,a; Uurtio et al., 2018a).
The HSIC is an indicator of (in)dependency for two universal kernel (Ha andHb) and
can be apply in non-linear CCA, (Gretton et al., 2005a; Uurtio et al., 2018a).
From Section 3.3.2 of the previous chapter, we know that the sparsity can be inducted
into the CCA by applying l1-norm on the canonical weight vectors in the constraint of
CCA. The level of this sparsity can be control through the l1-norm constants c1 and c2
for each view a and b and a sparse subset of variable is selected by canonical weight
vectors u ∈Rp and v ∈Rq .
Additionally, non-linear relation between these variables can be obtained by using
Gram matrices Ku and Kv where Ku = 〈uT xia ,uT x ja〉 and Kv = 〈vT xib ,vT x
j
b〉, and i and
j indicate two different samples in views a and b. Thus, the HSIC-SCCA model is
calculated by optimizing Equation 57
max
s.t .
ρ(u,v)= tr ace(Kˆ
uKˆv)
(n−1)2 =
∑
i j
∑
pq k
u
i j k
v
pq
(n−1)2 ,
‖u‖1 ≤ c1
‖v‖1 ≤ c2
(57)
where n indicate the number samples, kui j and k
v
pq refer to entries of centered kernels
obtained from projected samples of views a and b respectively. Additionally, c1 and c2
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refer to l1-norm constant and control the level of sparsity (Uurtio et al., 2018a). It is
possible to use the l2-norm regularization instead of the l1-norm in the situation that
sparse subset of variables is not required. That is, the l2-norm can easily substitute the
l1-norm. This method is called HSIC-CCA and has been proposed in the (Chang et al.,
2013). Additionally, the l1-norm can be applied to one of the views while the l2-norm is
used for the other one. By using l2-norm the non-sparse projection vector for features
is obtained and it is beneficial for the cases that sparse projection is not demanded
(Uurtio et al., 2018a).
In order to obtain several canonical correlations, a deflation approach has to be
taken. Deflation refers to the operation of removing the influence of an eigenvector by
setting the corresponding eigenvalue of the eigenvector to zero. The Schur complement
deflation techniques have been used in order to preserve the positive semidefinite of
the data matrix (Mackey, 2009). Assume the m-th canonical weight vector, um and vm ,
for m-th canonical correlation component is calculated for data matrices Xa and Xb.
The m+1-th orthogonal canonical weight vectors, u(m+1) and v(m+1), can be obtained
by applying Equation 57 to the data matrices obtain in Equation 58.
X(m+1)a =X(m)a −
u(m)u(m)
T
X(m)a
u(m)u(m)T
,
X(m+1)b =X(m)b −
v(m)v(m)
T
X(m)b
v(m)v(m)T
,
(58)
where X(m)a and X
(m)
b are m-th data matrices in view a and b. This step guarantee that
all calculated canonical weight vectors, (u(1),u(2), · · ·) and (v(1),v(2), · · ·), are mutually
orthogonal (Uurtio et al., 2018a).
A recursive algorithm is suggested in (Uurtio et al., 2018a) to extract the m different
non-linear relations between features of two views Xa and Xb . This algorithm is pre-
sented in Algorithm 2.
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Algorithm 2: Sparse Non-linear Canonical Correlation Analysis Algorithm
1 Inputs: Xa , Xb , ²(convergence limit),
M (number of component),
R (number of repetition),
pa (l1 or l2 norm type for u),
pb (l1 or l2 norm type for u),
c1 (regularization parameter for view a),
c2 (regularization parameter for view b),
δu (parameters for Ku),
δv (parameters for Kv )
2 Outputs: u and v
3 for m=1,2, · · · , M do
4 for r=1,2, · · · ,R do
5 Initialize umr and vmr
6 Compute Ku , Kv and Kˆv
7 repeat
8 Compute fol d = ρ(u,v)
9 ComputeOu = δρ(u,v)δu
10 Update umr =Π‖·‖px≤c1 (umr +γOu)(line search to determine the stop
size γ along the gradient)
11 Compute Ku , Kˆu
12 ComputeOv = δρ(u,v)δv
13 Update vmr =Π‖·‖py≤c2 (vmr +γOv)(line search to determine the stop
size γ along the gradient)
14 Compute Ku , Kˆu
15 Compute fcur r ent = ρ(u,v)
16 until | fol d − fcur r ent | < ²;
17 fr = fcur r ent , ur =umr , vr = vmr
18 end
19 Select r ∗ = ar g max fr ,
20 Store U(:,m)=ur∗ , V(:,m)= vr∗
21 Deflate X(m)a , X
(m)
b by U(:,m) and V(:,m)
22 end
23 return u, v
As it can be seen in the Algorithm 2, first the type of regularization technique,
l 1−nor m or l 2−nor m, and their values, c1, c2 are specified. Additionally, the number
of components that are desired to obtained and the number of repetition has to be
specified. In the sparse canonical correlation analysis algorithm, the projection vectors
of each view are initialized randomly. The number of repetition indicates the number of
random initialization of the projection vectors. The hyper-parameters for the kernels of
each view are specified by δu and δv . The convergence limit, ², is the stopping criteria
of the algorithm. That is, for each component the optimization continues until the
difference between HSIC measurements of the previous step and the current step is
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smaller than ². In order to optimize for both projection vector, u and v, a stochastic
gradient has been applied. That is, in each iteration a mini-batch of instances, i and
j , has been selected randomly and the gradient of kernel function with respect to
projection vector u and v,Ou andOv, has been calculated with respect to the selected
instances. The stochastic gradient has been proposed since the calculation for the exact
gradient is too costly, O (n2d) (Uurtio et al., 2018a).
3.4 Model Selection And Model Evaluation
In order to model selection and model evaluation, a different variation of cross-
validation (e.g. CV) can be used. In this technique, the data set under study is divided
into two parts; one for the model selection, training data set, and the other for evaluation,
test data set. In the model selection step, the model parameters are selected in order to
the predictive model to obtain the best performance on the train data set. The accuracy
of this optimal model is evaluated on the test data set which has not been seen before
by the model in the training step (Krstajic et al., 2014).
3.4.1 K-Fold Cross-Validation
In the K-fold cross-validation technique, the dataset is partitioned into k equally
sized segments. Additionally, accuracy criteria, such as the Pearson correlation, and
an initial range of values for each model parameter is considered. Then an irritate
algorithm obtain the accuracy of the model for all parameters in the given range. At
each iteration, one of the partitions is used as a test set and K −1 folds are used for
training the model. After obtaining the accuracy of the optimal model on the all iteration
of test folds, the average prediction performance is reported as total model accuracy,
(Krstajic et al., 2014).
3.4.2 Nested Cross-Validation
IIn the nested cross-validation technique, two-layer cross-validation is employed
to select and evaluate a model. Same as the k-fold cross-validation, the data set is
partitioned into the k different segments with equal size. These partitions are considered
as the outer loop. At each iteration of the outer loop, one partition is considered for
performance evaluation (test) and the rest folds are for model selection (train). Then
the train set divided to n partition of equal size. These are inner loops which in them
all combination of parameters are tested in the same as k-fold cross validation manner.
The best parameters are selected based on the best performance of inner loops. These
parameters are used in the training the model by an outer loop train set and tested on
the test set of the outer loop. Similarly to the K-fold cross-validation, the accuracy of the
model is reported by averaging over the accuracy of the result for outer loops (Krstajic
et al., 2014).
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4 Materials and Methods
In this chapter, first we go through the data sets that have been used in this study,
Genomics of Drug Sensitivity in Cancer (e.g. GDSC) data set. Two methods, KCCA and
HSIC-SCCA, are used for selecting features from cell line and drug compound data
matrices of the given data set. The power of these methods, in selecting more relevant
features, are evaluated by the accuracy of the model constructed by these features in
prediction of drug sensitivity values. The work-flow of these experiments setups are
presented fully in this chapter. Firstly, we introduce the data set that has been used in
this study. After introducing the data set, the pre-processing step for the data set has
been explained. At last, the setup of the experiments is presented.
Through this Chapter, the drug sensitivity data matrix is referred as Y ∈Rn×m where
rows are referring to drug compounds samples, whereas, cell lines samples are stored
in columns. The cell lines data matrix, that comprises cell lines samples (rows) and
gene expression values as features (columns) is indicated by Xc ∈ Rm×q . The drug
compounds data matrix, that store the drug compounds samples (rows) expressed
by their fingerprints (columns), is indicated by XD ∈ Rn×p . Additionally, The drugs
sensitivity responses kernel, cell lines kernel, and drug compounds kernel are indicated
by KR ∈HR , KC ∈HC , and KD ∈HD and calculated by the Equation 59.
KR = 〈φR (yi ),φR (Y j )〉,
KC = 〈φC (xic ),φC (x jc )〉,
KD = 〈φD (xid ),φD (x
j
d )〉,
(59)
where φR (·),φC (·),φD (·) indicate the non-linear maps from the drug sensitivities input
space, cell lines input space, and drug compounds input space to a non-linear feature
space, respectively.
4.1 Genomics of Drug Sensitivity in Cancer (GDSC) Data set;
A subset of the large data set, Genomics of Drug Sensitivity in Cancer (i.e. GDSC),
has been used in this study. Genomics of Drug Sensitivity in Cancer project has been
initiated by Welcome Sanger Institute. This project has provided one of the largest
publicly available data set for drug responses on the cancer cell lines since it has been
established. GDSC contained the cancer drug sensitivity results of 73169 experiments
only on its second released version (July 2012) that includes drug responses of 138
anticancer drugs on the range 329-668 cancer cell lines per a drug. This data set has been
collected in order to facilitate the understanding of molecular and genomic changes
under influence of drugs in the cancer research field, and it has been accompanied with
detailed genomic data sets of cell lines (Yang et al., 2012).
4.1.1 Drug Sensitivity Data Matrix
A subset of GDSC data set has been selected for investigating the power of kernel CCA
and HSIC-SCCA methods to extract the important features among the cell lines data
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set, and drug compounds data set. That is the gene expression and fingerprints that are
highly correlated with drug sensitivity values in non-linear space. Our data set is a subset
comprises of 124 cell lines and 124 drug components that the drug responses are fully
calculated. These drug-cell line responses are measured by fitting the dose-response
curve through 9 points drug concentration measurements observed during 72 hours
of drug treatment for each cell lines. These values are summarized as the natural log
of IC50 value (micromolar concentration of a drug that inhibits half of the cell growth)
(Ammad-ud din et al., 2016; Yang et al., 2012). The heat-map of this data matrix is
illustrated in the Figure 5.
Figure 5: The heat-map of Drugs Responses data matrix. This data matrix contains the
responses of 124 cell lines (columns) to 124 drugs (rows).
4.1.2 Cell Line-Gene Expression Data Matrix
Additional to the drug sensitivity data matrix, which is used for both feature selection
task as input and later as the evaluation criteria, we require the genomic information of
the cell lines. Therefore, the values of baseline gene expression measurements for all of
the cell lines are used to capture genomic properties of cell lines. This data set contains
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13321 gene expression values (Ammad-ud din et al., 2016). Figure 6 illustrate the gene
expression data matrix for cell lines.
Figure 6: The heat-map of gene expression of cell lines. This data matrix contains the
responses of 124 cell lines (columns) to 124 drugs (rows).
4.1.3 Drug Compound-Fingerprints Data Matrix
In this study, a subset of 124 drug compounds, comprises of both FDA approved
drugs and under investigation chemical compounds, among the complete set of drugs in
the GDSC data set is selected. These drugs are presented by their primary names that can
be used to extract their SMILES by using Identifier Exchange Service of PubChem web
interface (Kim et al., 2018). Then, these SMILES are used to obtain the fingerprints of
the drugs and chemical compounds by the RCDK library in the R open-source software
(i.e. R: A language and environment for Statistical Computing) (Guha et al., 2007; R
Core Team, 2013). As a result, 10 different fingerprints are obtained. These fingerprints
and their description are presented in the following. At first, each individual fingerprint
was studied to obtain the features by HSIC-SCCA algorithm. However, the HSIC-SCCA
algorithm was not successful to obtain features that maximize the correlation between
obtained HSIC-SCCA variables. Therefore, we construct the drug compound data matrix
by combining all 10 different fingerprints. After combining all 10 different fingerprints
and removing duplicated features, the size of the variables is equal to 6103.
Standard fingerprint is 1024-bit fingerprint. This fingerprint is a path-based finger-
print. That is, each fingerprint is obtained by analyzing all different fragments of the
molecule following a linear path. This path is limited to a certain number of bonds.
Then every one of these paths is hashed to create the fingerprint. The length of the path
is adjustable but the default length is 1024 (Cichon´ska et al., 2018; Guha et al., 2007;
Cereto-Massagué et al., 2015).
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Circular fingerprint is a 1024-bit fingerprint. This fingerprint, also called extended
connectivity fingerprint (ECFP), is circular fingerprint with a maximum diameter equal
to 6. In the circular type of fingerprints, instead of studying the chemical compounds in
a linear path (starting from an atom and meet all other atoms of the chemical compound
in a specific order), each arbitrary atom of a given chemical compound is considered as
a center and the environment of this atom is studied up to a limited radius (Cichon´ska
et al., 2018; Cereto-Massagué et al., 2015; Rogers and Hahn, 2010).
E-state fingerprint is a 79-bit fingerprint. Each bit corresponds to E-state, electro-
topological state for atom electronic and topological characterization, properties of
each atom in the molecular graph. E-state refers to the basic electronic state of an atom
disturbed by the electronic influence of all other atoms in the molecule (Hall and Kier,
1995).
Extended fingerprint is a 1024-bit fingerprint. This fingerprint is a path-based finger-
print, similar to the standard fingerprint, but considers the connectivity between the
atoms (Cichon´ska et al., 2018; Willighagen et al., 2017).
Graph fingerprint is a 1024-bit fingerprint. This fingerprint is path-based, similar to
the standard fingerprint, but considers the connectivity between the atoms (Cichon´ska
et al., 2018; Willighagen et al., 2017).
Hybridization fingerprint is 1024-bit fingerprint. This fingerprint is path-base, same
as standard fingerprint, that only considers hybridization state (e.g. the angle between
different atoms in the arbitrary chemical compound) and not aromaticity perception
(Cichon´ska et al., 2018; Floris et al., 2014).
KR (KlekotaRoth) fingerprint is 4860-bit fingerprint. Each bit indicates the existence
of a unique substructure. These unique substructures were generating by fragmenting a
subset of Chambridge Diverse Set E library which had a positive effect on 24 cell-based
examined assays (Klekota and Roth, 2008).
MACCS fingerprint is a 166-bit fingerprint. Each of these bits refers to a MACCS
structural key that indicates different properties such as the number of atoms, bond, and
custom properties. The mapping of these properties into a structure and consequently
into the keybits is under software control (Keys, 2005; Durant et al., 2002).
PubChem fingerprint is an 881-bit fingerprint. Each bit refers to the presence of a
substructure. These substructures set cover wild range of features, such as element
counts, a different type of rings, atom pairs and many others (Bolton et al., 2008).
Short Path fingerprint is 1024-bit fingerprint. This fingerprint considers the shortest
path between a pair of atoms. Additionally, it takes into account the ring systems and
charges (Cichon´ska et al., 2018).
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4.2 Pre-processing of Data sets
Due to the high number of variables in both drug compounds data set and cell
lines data set, we perform a pre-processing step to reduce the number of features. This
step was necessary in order to reduce the dimension of the data set and consequently
reducing the consumed time for feature selection step.
In the cell line data set XC , the genes were selected by the variance of their expression
values. At first, the variance of each gene expression overall cell line samples have been
calculated. These values are in the range [0,18.92]. The histogram of these values is
illustrated in Figure 7.
Figure 7: Histogram of gene expression variances.
As it can be seen in Figure 7, many of gene expression values have variances close to
zero. Therefore, in the next step, the genes that have variances higher than 4 are selected.
The number of genes that have variance higher than 4 is equal to 2067.
In the drug compound data matrix XD , the features are binary, 0,1, values. Therefore,
in order to remove the low variance features in this binary data set, the ratio of value
one for each feature in all drug samples has been calculated. The histogram of the ratio
of one in each feature is illustrated in Figure 8.
In Figure 8, on the x-axis, the ratio of the number of drugs that contain value one
for an arbitrary variable to the total number of drugs is indicated. On the y-axis, the
frequency of obtaining the same ratio for different variables are presented. Thus, on the
x-axis values close to zero indicate that the frequency of values one in the corresponding
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Figure 8: Histogram of the ratio of value 1 in each variable in drug data matrix.
variables are low and values close to one demonstrate that many of drug compounds
have the value equal to one for the corresponding feature. Therefore, the variance
among those features is low. The range (0.4,0.6) has been selected to improve the
variance of features. The obtained data set comprises of 588 fingerprints as features.
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4.3 Experiments
The drug sensitivity values are predicted by the pairwise kernel ridge regression
method. In order to study the non-linear relations between samples and finding the
meaningful model based on it, the Gaussian kernel has been used in both steps; feature
selection, and regression prediction. This kernel is considered as one of the most
popular candidates to study similarity-based prediction especially for the real values
such as gene expressions of the cell lines. This kernel is presented in Equation 60.
kx(x
i ,x j )= exp(−‖x
i −x j‖2
2σ2
), (60)
where xi and x j both are individual samples from cell line data set or drug compound
data set. The parameterσ indicates the width of Gaussian kernel (Cichon´ska et al., 2018;
Shawe-Taylor et al., 2004). The σ parameter is estimated by using Median heuristic.
That is, the Euclidean distances between all pairs of samples are calculated and then the
median of them has been selected as Gaussian width parameter (Flaxman et al., 2016).
4.3.1 Drug Sensitivity Prediction With Pairwise Kernel Ridge Regression
The pre-processed cell line and drug compound data matrices, XC ∈Rn×p and XD ∈
Rn×q where n = 124, p = 2067 and q = 588, are used to predict the drug sensitivity
values by adopting kernel pairwise ridge regression. The drug sensitivity data matrix,
Y, contains responses of 124 cell line samples to 124 drug compounds. Additionally,
the Gaussian Kernel has been adopted to induce the non-linearity. That is, KC and KD
indicate the cell lines and drug compounds Gaussian kernels and they are presented in
the Equation 61.
kC (x
i
C ,x
j
C )= 〈φ(xiC ),φ(x
j
C )〉 = exp(−
‖xiC −x
j
C‖2
2σ2
)
kD (x
i
D ,x
j
D )= 〈φ(xiD ),φ(x
j
D )〉 = exp(−
‖xiD −x
j
D‖2
2σ2
),
(61)
where xiC ,x
j
C refer to the individual cell lines, and x
i
D ,x
j
D indicate the individual drug
compounds. φ refers to the mapping from input space to high-dimensional feature
space for both cell lines and drug compounds data sets, φ : xD ∈XD →φ(xD ) ∈HD and
φ : xC ∈XC →φ(xC ) ∈HC . The σ value for both kernels are estimated by the Median
heuristic. The Kronecker product of calculated drug kernel, KD ∈ R124×124, and cell
line kernel, KC ∈R124×124, is obtained for prediction by pairwise kernel ridge regression
method. This kernel obtained by the Equation 62.
K=KD ⊗KC =

kD (x1D ,x
1
D )KC kD (x
1
D ,x
2
D )KC · · · kD (x1D ,xnD )KC
kD (x2D ,x
1
D )KC kD (x
2
D ,x
2
D )KC · · · kD (x2D ,xnD )KC
...
...
. . .
...
kD (xnD ,x
1
D )KC kD (x
n
D ,x
2
D )KC · · · kD (xnD ,xnD )KC
 . (62)
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The kernel K can be used to obtain the solution for the pairwise kernel ridge regression
when the KD and KC are the inner product between train samples of cell lines and
drug compounds. The vector model parameter, α= (α1, . . . ,αN ), is calculated by the
Equation 63.
α= (K+λIN )−1 y, (63)
where N is equal to the number of samples in cell lines train dataset, nc , times
number of samples in drug compounds train dataset, nd , and I in N ×N identity matrix,
and λ is regularization parameter adjust the empirical error and model complexity
(λ> 0). Then, the prediction for a test pair (xD ,xC ) is calculated by the Equation 64.
f (xD ,xC )=
N∑
l=1
αl k((xlD ,x
l
C ), (xD ,xC ))=αT k, (64)
where k is a column vector with kernel values between train samples pair of cell lines
and drug compounds, (xlD ,x
l
C ), and test pairs, (xD ,xC ).
In this study, we used the pairwise kernel ridge regression implemented in RLScore
package. This implementation adopts several properties of the Kronecker product
of two matrices for a fast and memory efficient calculation of pairwise kernel in the
pairwise ridge regression. Therefore, this package enhances the model construction
and prediction of large data sets (Pahikkala and Airola, 2016).
4.3.2 HSIC-SCCA As Feature Selection Step For Prediction Of Drug Sensitivity Val-
ues
The HSIC-SCCA method has been adapted, in order to obtain a sparse set of features
for cell lines and drug compounds, that have a high correlation with drug sensitivity
values in the non-linear space. In this experiment, each of cell line data set and drug
compound data set, XC and XD , has been paired with the drug sensitivity data matrix,
YR separately and constructed the view A and view B of HSIC-SCCA method. Later,
the projected vectors obtained by HSIC-SCCA method for cell line dataset and drug
compound data set are used to calculate a sparse projection of features. The Gaussian
kernel has been used to calculate the KC and KD from the sparse projection of features
in the cell lines and drug compounds data set. At last, these kernels are used in the
kernel pairwise ridge regression method to construct the predictive model. In the figure
9 a schematic presentation of the work-flow of the experiment is given.
The sparse projection vectors for drug compound data set, uD ∈Rp , p = 588, and cell
line data set, uC ∈ Rq , q = 2067, are obtained by solving the HSIC-SCCA optimization
problem presented in the Equation 57 for both combinations of cell lines - drug sen-
sitivity data matrices (e.g. XC ,Y), and drug compound - drug sensitivity data matrices
(e.g. XD ,Y). These two optimization problems are presented in Equation 65.
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Figure 9: The work-flow for feature selection with HSIC-SCCA method and obtaining
the kernel for selected features. wR , wD , and wC are sparse projection vectors for drug
sensitivity responses, drug compounds, and cell lines data matrices respectively. ΦR ,
ΦD , andΦC are features maps for drug sensitivity responses, drug compounds, and cell
lines data matrices respectively. These kernels are used in the construction of an optimal
kernel pairwise ridge regression model to acquire the prediction for drug sensitivity
values.
max ρ(uC ,vR )=
tr ace(KˆuCC Kˆ
vR
R )
(n−1)2 ,
s.t . ‖uC‖1 ≤ c1 and ‖vR‖1 ≤ c2
max ρ(uD ,vR )=
tr ace(KˆuDD Kˆ
vR
R )
(n−1)2 ,
s.t . ‖uD‖1 ≤ c
′
1 and ‖vR‖1 ≤ c
′
2
(65)
where c1, c2 are optimized regularized parameter for the cell lines and drug sensitiv-
ity data matrices, and c ′1, and c
′
2 are optimized regularization parameter for the pair
drug compounds and drug sensitivity data matrices. These regularization parameter
indicating the level of the sparsity of projection vectors for the pair of data sets under
study. Gram matrices KˆuCC , Kˆ
uD
C , and Kˆ
vR
R indicate the centered Gram matrices that store
non-linear similarity of projected cell lines, drug compounds, and drug sensitivity data
sets. The Gaussian kernel has been used to obtain the non-linear relation between
projected samples. The Equation 66 illustrate the exact formulation of these kernels.
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(66)
After obtaining the Gaussian Kernels for projected drug compounds and cell lines
data set, KuCC and K
uD
D , these Kernel are used to obtain the pairwise kernel matrix K
in the Equation 62. The optimized model for the kernels of projected data sets can
be calculated by finding the vector of parameters α given in the Equation 63 and the
prediction is made by using this vector in the Equation 64.
4.3.3 KCCA As Feature Selection Step For The Prediction Of Drug Sensitivity Values
For selecting features in the cell line and drug compounds data sets with KCCA
method, the canonical weight vectors are obtained in the high-dimensional Repro-
ducing Kernel Hilbert Space (i.e feature spaces)HC andHD . Unlike the HSIC-SCCA
method, in the KCCA samples first, are mapped to high-dimensional feature space by
using the kernels. Then, the canonical projection vectors are obtained by maximizing
the correlation between canonical variables. The same as HSIC-SCCA step, the cell lines,
and drug compounds data sets are pair individually with drug sensitivity data set and
the canonical projection vectors of cell lines samples and drug compounds,αC andαD ,
are obtained separately by solving two optimization problem given in the Equation 67.
cos(zC ,zR )= max
zC ,zR∈Rn
〈zC ,zR〉 =αTC KTC KRβR ,
s.t αTC (KC + c1I)2αC = 1 and βTR (KR + c2I)2β= 1
cos(zD ,zR )= max
zD ,zR∈Rn
〈zD ,zR〉 =αTD KTD KRβR ,
s.t αTD (KD + c
′
1I)
2αD = 1 and βTR (KR + c
′
2I)
2βR = 1,
(67)
where zC , zD , zR are canonical variables for cell lines, drug compounds and drug sen-
sitivity data sets, respectively. KC , KD , and KR refer to the kernel matrices sample in
the cell lines, drug compounds, and drug sensitivity data sets. Additionally, c1 and c2
correspond to the regularization parameters for the pair cell lines and drug sensitivity
input, and c ′1 and c
′
2 indicate the regularization parameter for the pair drug compounds
and drug sensitivity data matrices. The canonical vectors αC , αD and βR are calculated
by the solving Lagrange multiplier equations.
The solution of canonical vectors, for cell line data setαC and for the drug compound
data set αD , that are calculated in the feature spaces of cell lines samples and drug
compounds, are of the size Rn where n = 124. Therefore, in order to calculate the cell
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lines and drugs compounds kernels of projected input data matrices, the obtained
canonical variables vector zC and zD of all projected samples are used. The similarity
between the samples in the high-dimensional feature space is obtained by Gaussian
kernel and stored in the KC and KD . The Equation 68 shows the calculation of these
kernels
kαCC (x
i
C ,x
j
C )= 〈φ(ziC ),φ(z
j
C )〉 = exp(−
‖ziC −z
j
C‖2
2σ2
)
kαDD (x
i
D ,x
j
D )= 〈φ(ziD ),φ(z
j
D )〉 = exp(−
‖ziD −z
j
D‖2
2σ2
),
(68)
where vector ziC and z
j
C store canonical variables of different components of individual
samples in projected cell line data set, and ziD and z
j
D indicate the vector of canonical
variables of different components in the projected drug compounds data set. Same
as HSIC-SCCA, the pairwise kernel matrix K given as in the Equation 62 is obtain by
Kronecker product of these Kernels and the optimal model is constructed by using this
pairwise kernel in kernel ridge regression method.
4.3.4 General Protocols
In the all aforementioned experiments, the optimal model to predict the drug sensi-
tivity values is obtained by the kernel ridge regression. The root mean-squared error
(RMSE) has been used as model selection criteria for kernel ridge regression. The reason
for such selection is that the RMSE follows the same scale as the original data set, thus it
is often preferred over mean-squared error Hyndman and Koehler (2006). Additional
to the RMSE criteria, Pearson correlation, Spearman’s rank correlation, and c-index
(concordance index) are reported for the generalization error of the optimal model.
Additionally, the regularization parameter of kernel ridge regression is selected by
leave pair out 5×3 nested cross-validation technique. The term leaves pair out (LPO)
refers to the fact that the cell line and drug compound pairs in the train data set are
not shared with the test data set. Therefore, the pairs in the test dataset are not seen by
the obtained optimal model on the train set. The LPO technique eliminates the bias
factors in the model evaluation step Pahikkala et al. (2013). A grid search over 10i for
i ∈ {−3,−2,−1,0,1,2,3} was performed to select the optimal regularization parameter in
pairwise kernel ridge regression. Additionally, the same train and test samples are used
in the outer folds of all experiments in order to make a more accurate comparison. In
the next chapter, the results of these experiments are presented and discussed in details.
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5 Results And Discussion
The objective of this thesis is to study the effect of feature selection in drug sensitivity.
In order to accumulate the features, which increase the correlation of drug compounds
and cell lines with drug sensitivity, two methods HSIC-SCCA and KCCA, has been
adopted. The accuracy of the obtained features is evaluated by the accuracy of the
prediction made by the optimal model. In order to construct the optimal model, the
pairwise kernel ridge regression has been adopted. In the following, the results of three
different experiments, pairwise kernel ridge regression, HSIC-SCCA as feature selection
step, and KCCA as feature selection step on the prediction of the drug sensitivity is
presented. First, we present the results of the prediction of the optimal model obtained
by pairwise kernel ridge regression method on the re-processed data. Then the effect of
feature selection by HSIC-SCCA, for pre-processed data, is demonstrated. In the end,
the KCCA has been employed as an alternative feature selection technique to compare
with the HSIC-SCCA method.
5.1 Drug Sensitivity Prediction With Pairwise Kernel Ridge Regres-
sion
In this experiment, the pairwise kernel is constructed by the Kronecker product of
two Gaussian kernels. The cell line kernel KC ∈HC and drug kernel KD ∈HD . This
pairwise kernel is used for obtaining the optimal model by pairwise kernel ridge regres-
sion method. A nested 5×3 cross-validation partitions the input data sets into the 5
different outer folds randomly. Therefore, 4 train folds comprise of 100 cell lines and
drug compounds samples, and one of the train folds contains 99 samples. In each fold,
the optimal regularization parameter has been selected based on averaged accuracy of
3 inner folds. Then, the obtained regularization parameter has been used for training of
the model for all the train samples in the outer fold. At last, this optimal model has been
used for predicting the drug sensitivities in the outer test fold.
There is a great difference between the distributions of the train and test folds in
each iteration. This difference is perceptible in Figure 10. The top row of the figure
illustrates the distribution of the drug sensitivity values in the different train and test
folds in two histograms. The top left histogram presents the labels in the train folds
and the top right plot shows the distributions of label values for test folds. The different
folds are indicated by different colors. The two scatter plots on the bottom row indicate
the correlation between the prediction of the optimal model, on the x-axis, and the real
values, on the y-axis, of the train (bottom left) and test (bottom right) folds. As it can be
seen in the bottom left scatter plot, the model is able to learn from the train samples but
this obtained model has not achieved high performance on the test samples. This can
be explained by the wild differences between the train folds and test folds. Thus, due to
these differences, the optimal models learned from the train folds cannot achieve high
performance on the test folds.
As It is presented in Figure 10, the average RMSE obtained for the model obtained
by pairwise kernel ridge regression method is equal to 2.96 with standard deviation
equal to 0.17. The overall C-index of the model is equal to 0.62 with standard deviation
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equal to 0.05. The Pearson correlation value for this model is equal to 0.45 with standard
deviation equal to 0.14 and the Spearman correlation criteria is equal to 0.35 with
standard deviation equal to 0.15. The high standard deviation over 5 folds for all accuracy
criteria is strong evidence of the high diversity between samples of the train and test
folds. In the next section, we want to reduce this diversity by adopting HSIC-SCCA
technique as a feature selection step.
Figure 10: Pairwise ridge regression prediction for train and test folds of the pre-
processed cell line and drug compounds data-sets. Each fold is indicated by a different
color. The top left plot illustrates the distribution of the drug sensitivity values for train
folds, the top right plots indicate the distribution of the same measurements in the test
folds. The two scatter plots in the bottom row illustrating the prediction of the optimal
model for train folds (left) and test folds (right).
5.2 The effect of HSIC-SCCA as Feature Selection Step
In this part, we explain the result of HSIC-SCCA method as a feature selection step.
We study the effect of selected features from cell lines and drug compounds data matri-
ces that have a high correlation with drug sensitivity values in non-linear feature space.
These features are selected by a sparse canonical vector and stored in the canonical
variables. The HSIC-SCCA method benefits from stochastic projected gradient descent
algorithm and finds the optimal projection vector by selecting small batches of samples
in iterative steps. This algorithm initiates with a projection vector randomly. Through
our experiments, we noticed that the random initialization of the projection vector has
a dramatic effect on the convergence of the optimizer. In other words, this algorithm
can converge to the different local minimal depending on the random selection of
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the initial projection vector. In order to overcome this difficulty, the number of ran-
dom initialization of the projection vectors was set to 30. Other criteria for obtaining
optimal projection vector were the maximum number of iterations and convergence
limit. Selecting small values for each of these parameters can cause the algorithm to
suffer from an early stopping point. Therefore, I set the convergence limit, ² to 10−7,
and the maximum number of iteration to 500. The learning curve of best projection
vector obtained by the HSIC-SCCA method in each fold for both pairs of cell lines - drug
sensitivity data matrices (XC , YR ), and drug compounds - drug sensitivity data matrices
(XD , YR ) are presented by the mean and standard deviation over 5 train folds in the
Figure 11. All the learning curves in Figure 11 illustrate the first component obtained by
HSIC-SCCA for drug compounds data matrix (left) and cell lines data matrix (right).
Figure 11: The overall learning curve of the best HSIC-SCCA projection vectors achieved
for the first components in different 5 train folds by the mean and standard deviation
over 5 train folds. The left plot presents the learning curves for the first components of
five different train folds for drug compounds data matrix. The right plot illustrates the
learning curves for the first components of five different train folds for cell lines data
matrix.
Figure 11 illustrates that in most of the cases, the algorithm stops before the max-
imum iteration has been met. That is due to the fact that the minimum convergence
criteria have been met. As it can be seen in Figure 11 in the different folds, the Algorithm
has converged to the different local minima. This is because of two reasons. First,
the diversity of samples between different folds that causes the selection of different
optimal projection vectors. Second, the randomly initializing of projection vectors. The
effect of these two factors can be observed more vividly in Figure 12. In this figure, the
HSIC-SCCA score for train and test folds of 10 different components over five folds is
presented by their mean and standard deviation.
In Figure 12, the left plot illustrates the results for drug compounds data matrix and
the right plot presents the results of cell lines data matrix. Ideally, the HSIC-SCCA score
of different components should reduce as we are removing stronger variables in each
obtained component by deflation techniques. However, the plots in Figure 12 illustrate
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different reality. This is due to the fact that random initialization point causes the
algorithm to fall in different local minima. Therefore, the subset of features selected in
different components is equally good in most of the time. The higher range of standard
deviation is another factor that demonstrates the effect of random initialization for the
projection vector and diversity among the samples in different folds, as high standard
deviation indicates the high difference between HSIC-SCCA value for a component
among different folds.
Figure 12: The illustration of HSIC-SCCA scores for 10 different components over 5 outer
folds of cross-validation by their means and standard deviations.
The HSIC-SCCA variable for each component is obtained by inner product between
the data matrices and the optimal projection vectors in the different folds. In order
to study the accuracy and effect of these projection vectors on the different train and
test folds, we plot each of these HSIC-SCCA variables in a score plot. The score plot
is a 2D dimensional presentation of canonical variables, where one axis refers to the
obtained canonical variables of one view (such as drug compounds or cell lines data
matrices), whereas the other axis presents the canonical variables of the other view
(drug sensitivity data matrix). These results are presented in Figure 13. In this figure, the
first component of different folds is presented in different colors. The first row of this
plot presents the results of canonical variables for the train (left) and test (right) folds of
the pair drug compound data matrix (x-axis) and drug sensitivity data matrix (y-axis).
The second row of this plot illustrates the canonical variables of cell lines data matrix
(x-axis) and the drug sensitivity data matrix (y-axis).
The obtained canonical variables yield high correlation in the non-linear feature
spaces, therefore, the aim of this plot is not illustrating the correlation between two
canonical variables of each view of a plot, but to studying whether the projection vector
successfully captures the similar pattern in the train and test folds. As it can be seen in
Figure 13, the similar pattern between the same train and test of each fold is obtained.
That is, the HSIC-SCCA was able to capture the strong variables in each fold that was
equally explanatory in the test folds. The HSIC scores for the cell lines data set are higher
than the HSIC score of drug compounds data set in general. This is due to the higher
number of features that have a stronger correlation with drug sensitivity.
47
The differences between the HSIC scores of train and test folds is due to the high
difference between samples of the train and test folds. Even though the HSIC-SCCA
algorithm managed to extract the features that result in a high correlation between two
views of a training fold, but some of these features could have really low values in the
understudying test fold. Therefore, the test values of the HSIC score are lower in test
folds.
Figure 13: Score plots for pairs drug compound data matrix and drug sensitivity (first
row), the x-axis refers to the drug compound variables and the y-axis refers to the drug
sensitivity variables. The pairs consist of cell lines data matrix and drug sensitivity are
presented in the (second) row, the x-axis refers to the cell line variable and the y-axis
refers to the drug sensitivity variables. The left plots in both rows refer to the training
folds and the right plots refer to the test folds.
Now we want to see the effect of the feature selection with HSIC-SCCA algorithm
on the prediction of drug sensitivity values. The same as the previous experiment, the
pairwise kernel ridge regression in the RLScore package has been adopted for prediction
of drug sensitivity values. The HSIC-SCCA variables of cell lines data matrix and drug
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compound data matrix obtained by the first component has been chosen and the cell
lines kernel, KC , and drug compounds kernel, KD are obtained by applying the Gaussian
kernel on these HSIC-SCCA variables. These kernels were used by the pairwise kernel
ridge regression method to obtain the optimal model. The prediction results of pairwise
kernel ridge regression are illustrated in Figure 14.
Figure 14: Pairwise ridge regression prediction for train and test folds of cell lines and
drug HSIC-SCCA canonical variables. Each fold is indicated by a different color. The top
left plot illustrates the distribution of the drug sensitivity values for train folds, the top
right plots indicate the distribution of the same measurements in the test folds. The two
scatter plots in the bottom row illustrating the prediction of the optimal model for train
folds (left) and test folds (right).
As it can be observed in Figure 14, the accuracy of the prediction obtained by HSIC-
SCCA variables is lower than the original data matrices. The RMSE of the prediction in-
creased to 3.13 with higher standard deviation equal to 0.43, the C-index value dropped
to 0.56 with standard deviation equal to 0.62, the both Pearson correlation and Spear-
man rank correlation have decreased to 0.38 with standard deviation 0.28 and 0.18 with
standard deviation equal to 0.18 respectively. This is due to the fact that differences
between the train and test folds have increased by adopting HSIC-SCCA. As we pointed
it out previously, due to the fact of random initialization of projection vector and high
diversity between samples, the HSIC-SCCA algorithm has converged to different local
minima, therefore, different variables have been chosen by the algorithm among all
features. That is, the sparse subset of features obtained by the algorithm in the different
training folds cannot extract the strong features in the test fold. Although the score plots
in the Figure 13 illustrate the similar pattern between the train and test folds, still the
HSIC-SCCA canonical vectors increase the diversity between the samples, therefore; the
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accuracy of the prediction of pairwise kernel ridge regression is reduced.
In order to reduce the diversity between the samples of different folds after the
feature selection, a rotational technique has been adopted. In this technique, the HSIC-
SCCA variable of one fold has been chosen as a destination and all other HSIC-SCCA
variables in the other folds have been rotated in order to reduce the distances between
HSIC-SCCA variables of all folds. The rotation matrix for different folds is calculated by
Equation 69.
Q=U(1)XT XU(2)T (U(2)XT XU(2)T )−1, (69)
where Q refers to the rotation matrix for each fold, the normalized destination projection
matrix is indicated by U(1) ∈ Rp×t where p is equal to the number of features in the
corresponding data matrix and t is the number of components. X is the given data
matrix and U(2) present the normalized projection data matrix that we want to rotate.
This rotation is applied to the projection vectors obtained in different folds for both
views of pair cell lines - drug sensitivity and drug compounds - drug sensitivity by
the inner product of rotation matrix Q and the projection matrices U(2). By adopting
this technique we achieved more similar HSIC-SCCA variables for different folds. This
rotation has been applied to HSIC-SCCA variables of the drug sensitivity data matrix in
order to be able to illustrate the result in a score plot. These score plots are presented in
Figure 15.
In Figure 15, all the projection vectors of pair cell lines - drug sensitivity data matrices
are rotated to the first fold, and for the pair drug compound - drug sensitivity data
matrices all projection vectors are rotated to the fifth fold. This is because of the fact that
these folds illustrate a higher correlation between two views in the score plot of Figure
13. Additionally, the better rotation was obtained when 3 first HSIC-SCCA components
were considered for all folds. However, the rotation results yield better score plots for the
pair cell lines - drug sensitivity data matrices, the second row in Figure 15, for both train
and test folds. on the other hand, the rotation of the canonical variables of different folds
for the pair drug compounds - drug sensitivity data matrices scattered the HSIC-SCCA
canonical variables, especially on the test folds. This can be due to the fact that the
destination HSIC-SCCA variable, the canonical variable of the fold five that we want to
rotate all HSIC-SCCA variables of other folds to it, have more scattered scatter plot in
the Figure 13, even though it has high HSIC score.
In Figure 16 the accuracy of the prediction of the optimal model based on the
rotated HSIC-SCCA variables, obtaiened on the cell line and drug compound data
matrices, is presented. As can be seen in this figure, the accuracy of the prediction for
the test samples has slightly improved. The overall RMSE reduced to 2.83 with standard
deviation equal to 0.24, C-index slightly improved and reached to 0.63 with less standard
deviation 0.4, Pearson correlation increased to 0.5 with lower standard deviation equal
to 0.1, and the Spearman correlation reached to 0.39 with standard deviation equal to
0.1. The improvement of the results is due to the fact that the rotation of the projection
vectors decreases the diversity among the samples in the different folds, therefore, the
optimal model obtained from the training fold has a higher accuracy of the test fold.
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Figure 15: Score plots of pairs drug compounds - drug sensitivity data matrices (first
row) and the cell lines data - drug sensitivity data matrices (second row) after rotation
of projection vectors. The left plots in both rows refer to the training folds and the right
plots refer to the test folds.
These results indicate that the low prediction accuracy for features selection by HSIC-
SCCA is due to the High diversity among samples of different folds after projection. The
first row of Figure 16 presents the histogram of the drug sensitivity values in different
train (left) and test (right) fold. In the second row of this figure, the correlation between
the prediction values (x-axis) and real values (y-axis) of the different train (left) and test
(right) folds are illustrated.
5.3 The Effect of KCCA as Feature Selection Step
Based on the observation made on the feature selection with HSIC-SCCA, we decided
to evaluate the effect of non-sparse feature selection method on the prediction of drug
sensitivity values. The KCCA has been selected as our comparison model. In this model,
a regularised parameter is optimized on the train samples to prevent the model from
obtaining the canonical correlation equal to one. In order to obtain these parameters,
a 5-fold cross-validation technique has been used. After obtaining the regularization
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Figure 16: Pairwise ridge regression prediction for train and test folds of the pre-
processed cell line and drug compounds data-sets. Each fold is indicated in a different
color. The top left plot illustrates the distribution of the drug sensitivity values for train
folds, the top right plots indicate the distribution of the same measurements in the test
folds. The two scatter plots in the bottom row illustrate the prediction of the optimal
model for train folds (left) and test folds (right).
.
parameter, these values are used to obtain an optimal model. Then this model is applied
for the complete data sets to obtain the canonical variable. The experiment workflow
is the same as the implementation of KCCA in the paper “A Tutorial on Canonical
Correlation " (Uurtio et al., 2018b).
In the feature selection step for both data matrices in the pair drug compounds - drug
sensitivity data matrices a grid search over the value of the range {0.5,1,1.5,2,2.5,3,3.5,4,4.5,5}
has been made. The selected value for the drug compound data set is equal to 3 and
this value for the drug sensitivity data matrix is equal to 2.5. The canonical correlation
obtains for these regularized parameters on the train data set is equal to 0.2014, which
indicates that a high correlation between two data matrices of this pair could not be
found. These regularized parameters are adapted to construct a model and this model
has been applied to the complete data matrices in both views. The canonical correlation
of the first component for the pair drug compound - drug sensitivity data matrices is
equal to 0.63.
parameter for the data matrices of the pair cell lines- drug sensitivity data matrices.
The regularized parameter chosen by the algorithm for this pair data matrices is equal to
0.5 and 0.5, for cell line data matrix and drug sensitivity data matrix respectively. Since
the smallest values in the range have been chosen by the algorithm for both views, a
range constructed of the values in the set 10i where i ∈ {−3,−2,−1,0} has been tested.
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The same as the previous experiment, the smallest value, 10−3, has been chosen by
the algorithm. The canonical correlation for the train folds for both experiments is
equal to one. That is, due to a large number of features in the cell line data matrix, the
obtained canonical correlation scores for all the combinations of the values in the grid
search range are equal to one. This is due to the fact that the system under study is an
undetermined system. Additionally, by choosing the smallest tested values, 0.001, for
both regularized parameter the canonical correlation of the first component obtained
for the pair cell line - drug sensitivity data matrices is equal to one. On the other hand,
this value for the regularized parameters set to 0.5 in the same pair is equal to 0.95. This
indicates that the regularized parameter 0.5 can overcome the undetermined system
better; therefore, the value 0.5 has been chosen for the regularized parameter. The score
plot of the first component obtain by this procedure is illustrated in Figure 17.
Figure 17: Score plots of two pairs drug compounds - drug sensitivity data matrices (left)
and the cell line - drug sensitivity data matrices (right) for the first component obtained
for each pair of data matrices by KCCA algorithm.
The left score plot in Figure 17 present the pair drug compounds - drug sensitivity
data matrices. The pair of cell lines - drug sensitivity data matrices are presented in
the right score plot. On the other hand, the KCCA method has not achieved a high
correlation between the drug compounds and drug sensitivity data matrices. This can
be due to the high diversity between features of different samples. The correlation score
of 5 different KCCA components has been obtained and presented in Figure 18.
As it can be seen in Figure 18, the correlation score between two successive compo-
nents of the same pair is decreasing. This is due to the fact that these components are
obtained by the eigenvalue decomposition of two kernel matrices obtained from the
Equation 67; therefore, they are in descending order. The accuracy of the prediction for
the 5 variables obtained by adopting KCCA for feature selection is presented in Figure
19.
As it can be seen in Figure 19, adopting KCCA for the feature selection yield a similar
result as original data in the regression prediction step. The RMSE obtained by this
feature selection method is equal to 2.96 with the standard deviation equal to ±0.17, the
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Figure 18: Correlation scores for 5 first components of KCCA obtained from drug com-
pound - drug sensitivity data matrices (blue), and cell line - drug sensitivity data matrices
(red).
Figure 19: The accuracy of prediction obtained by five first components of KCCA ob-
tained from the pair drug compound - drug sensitivity data matrices, and the pair cell
line - drug sensitivity data matrices. The first row presents the histogram of the drug
sensitivity values for the different train (left) and test (right) folds. The second row of
the plot illustrates the correlation between the prediction values (x-axis) and real value
(y-axis) on the train folds (left) and the test folds (right).
C-index is equal to 0.63 with standard deviation equal to ±0.04. The obtained Pearson
correlation is equal to 0.46 with standard deviation equal to ±0.13 and the Spearman
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correlation is equal to 0.39 with standard deviation equal to±0.1. Although these results
are similar to the prediction made with pairwise kernel ridge regression without feature
selection step, they are better than the result obtained by adapting HSIC-SCCA method
for feature selection. This is because of the fact that the samples of the different folds
have lower variances compare to the case of HSIC-SCCA, after feature selection step.
The similarity between the result of this experiment with the experiment where no
feature selection step has been considered is because of the fact that by considering
five different canonical variables obtained from the KCCA for constructing the cell line
and drug compound kernel most of the features in both data set has been considered.
Therefore, the regression prediction for drug sensitivity values is similar for these two
experiments. In order to eliminate this problem, a smaller number of canonical variables
for both cell line and drug compounds data matrices has been selected.
By choosing the first three KCCA canonical variables for both drug compounds
and cell lines data matrices, the similar prediction accuracy, RMSE = 2.96±0.16, as
before has been obtained. However, when the number of chosen variables decreases to
one, the result of prediction has improved slightly. The RMSE obtained by first KCCA
variables is equal to 2.90 with the standard deviation equal to±0.19, the C-index is equal
to 0.63 with standard deviation equal to ±0.03. The Pearson correlation and Spearman
correlation are equal to 0.48±0.1 and 0.39±0.09 respectively. That is, the prediction
obtained by the first KCCA canonical variable result in better prediction than the model
build on by more than one canonical variables. This prediction result is better than
the result without feature selection, therefore; we can conclude that the first canonical
variables of both drug compound and cell line data matrices are more correlated with
the drug sensitivity values. Additionally, the result of first KCCA canonical variable is
not higher than the result obtained by using rotated HSIC-SCCA canonical variables.
This is due to the fact that in the KCCA method, use l2-norm regularized constraints,
therefore; all the features are selected in the canonical variables but they have different
weights that correspond to their ability to increase the correlation between two views
in the non-linear space. On the other hand, in the HSIC-SCCA method, a sparse set
of features is selected by l1-norm regularized constraints. That is, this method is able
to eliminate noise in the data matrices by choosing those features that improve the
correlation between two views in the non-linear space. The summary of the results of
all experiments is presented in Table 1.
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Experiment RMSE C-index
Pearson
correlation
Spearman
correlation
Pairwise KRR 2.96±0.17 0.62±0.06 0.45±0.14 0.35±0.15
HSIC-SCCA 3.13±0.43 0.56±0.06 0.31±0.21 0.18±0.18
Rotated HSIC-SCCA 2.83±0.24 0.62±0.04 0.50±0.10 0.39±0.10
KCCA (5 components) 2.96±0.17 0.63±0.04 0.46±0.13 0.39±0.10
KCCA (1st component) 2.90±0.19 0.63±0.03 0.48±0.10 0.39±0.09
Table 1: Table of results for five experiments. The pairwise KRR refers to the result
obtained by using pairwise kernel ridge regression for cell line and drug compound data
matrices. The HSIC-SCCA indicates the result of selecting cell line and drug compounds
features by using HSIC-SCCA method. The rotated HSIC-SCCA refers to the results
obtained by rotated canonical variables that are obtained by HSIC-SCCA from cell line
and drug compound data matrices. The KCCA (5 components) refers to the results
obtained by using five first components obtained KCCA method for cell line and drug
compound data matrices. The KCCA (1st component s) indicates the results obtained
by the first canonical variable obtained by KCCA from cell line and drug compounds
data matrices. All the results are presented by their means and standard deviations over
five outer folds.
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6 Conclusion
The objective of this thesis was to evaluate the performance of non-linear variation
of canonical correlation analysis, specifically Kernel CCA and HSIC-SCCA, in the feature
selection for prediction of the drug sensitivity values. Previous works indicate that kernel
methods are able to provide an accurate prediction by extracting non-linear relation
among features of input data sets. Additionally, this performance improves when both
cell lines and drug compounds data matrices are considered for obtaining the model.
Therefore, we applied a non-linear variation of the canonical correlation analysis to
extract features from both cell lines and drug compounds data matrices that are highly
correlated with drug sensitivity values in non-linear space. The aim of this step was to
improve the prediction accuracy by removing irrelevant features. Later, these features
are used to obtain a model by using pairwise kernel ridge regression method.
As it has been indicated in the result section, when working with the underdeter-
mined system, where the number of features is extremely higher than instances, the
performance of the predictive model can be affected greatly. This effect can be more
clear when the variance among the samples is high. In our study, the number of samples
for both cell lines and drug compounds data matrices are equal to 124, whereas, the
number of features in the pre-processed cell lines data set is equal to 2067 and the
number of feature in the pre-processed drug compounds data matrix is equal to 588.
Additionally, we observe a great difference between the distributions of drug sensitivity
values for different 5 folds.
All these facts, affect the performance of the predictive model. The benchmark
model, pairwise kernel ridge regression on the pre-processed data, achieved the accu-
racy of RMSE equal to 2.96, and C-index equal to 0.62. However, the feature selection
with HSIC-SCCA was not able to improve this result. The obtained accuracy by this
model is equal to RMSE = 3.13 and C − i ndex = 0.56. This can be explained by the
fact that the differences between samples of different folds have increased by adopting
HSIC-SCCA method as feature selection. In order to improve the result, we adopted a
rotation matrix obtained by three first canonical vectors of HSIC-SCCA to rotated the
canonical variables of different folds to the same origins. This technique improved the
accuracy of the prediction, and the RMSE of the obtained model reduced to 2.83 and
C-index criteria improved to 0.62.
As a comparison, we study the effect of KCCA as feature selection step. The results of
the predictive model obtained from five first KCCA variables was the same as the model
obtained on the original input data matrices. This is because of the fact that considering
five first KCCA variables combines all of the features, therefore; no improvement has
been observed. Hence, using only the first variable obtained by KCCA for both cell lines
and drug compounds slightly improved the accuracy of the obtained model. The RMSE
of this model is equal to 2.90 and the C-index is equal to 0.63.
Finally, the results suggest that sparse set of features obtained in the non-linear
feature space, by adapting HSIC-SCCA, can improve the prediction of the drug sensitivity
values but in some cases such as this study they can increase the difference among the
instances of different folds obtained by cross-validation technique. Thus, the accuracy
of the predictive model is reduced. Additionally, HSIC-SCCA can perform better in the
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cases that difference between the number of instances and the number of variables is
not high.
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